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I. SUMMARY AND CONCLUSIONS
Shifts in the patterns ofillness among AmericanIndianand AlaskaNative (AIl AN)commuities
underscore the need to better understand patterns and correlates of chronic disease. The
development of new knowledge that describes patterns of occurence and patterns of care for
chronic disease is critical to support the development and implementation of intervention
strategies to deal more effectively with a growing burden of illness due to chronic conditions.
Although cancer rates are generally believed to be relatively lower in AIl AN populations, the
available statistics suggest a relatively poor survival experience for cancer patients. This report
describes a series of six studies on cancer in American Indian and Alaska Native women, with a
particular emphasis on cancer of the breast and cervix. The work was supported with funds from
the Office of Planning, Evaluation, and Legislation of the Indian Health Service and from the
National Cancer Institute under contract Y02-CN-90667.
The six studies reported here bring to bear a substantial body of information with relevance to
IHS clinical policy. Although each study discusses its results in detail, several findings deserve
emphasis and others are most apparent when considered across several studies.
A. Burden of Cancer Illness
Perhaps the most important finding is that confirming the substantial varia.tion in cancer rates
among IHS administrative areas and among tribal groups. Breast cancer rates show substantial
variation among Areas and Tribes, but are consistently below that observed by the general U.S.
female population. Unlike the general population, however, for the All AN women the rates of
cervical cancer equal and may exceed the rates of breast cancer in someIHS areas. Hopefully, these
data will reduce the frequency of inappropriately general statements about the frequency of
cancer in AIl AN communities, and instead focus attention on the need for better explanations of
the observed variation and, most importantly, of the need for clinical policy that is consistent with
the rates observed in the local community.
There is less difference between AIl AN women and the general population for cancer
mortality rates. For all site incidence only the Alaska Area exceeded the general population, yet
for all site mortality the Billings and Aberdeen Areas also exceed the rates for the general
population. The relationship between incidence (new cases) and mortality should be interpreted
cautiously, and several factors may contribute to the relationship. First, the data were derived
from different sources and could result in relative under or overcounting of the cases, the deaths,
or the populations at risk. Second, the distribution of cancers by site may vary, with the Area
burdened by more lethal cancers showing a mortality rate out of proportion to the incidence.
Third, the mortality data are derived from death certificate data and do not distinguish among
individuals eligible and ineligible for IHS care. Consequently, the analysis used only those states
in which more than 80% of All ANs were believed eligible for care by the IHS. This procedure
resulted in sampling by state for some Areas, e.g., the mortality for the Billings Area represents
only cancer deaths in Montana. Finally, discrepancies in the incidence to mortality relationship
could result from variation in the adequacy of care by IHS Area, principally variation in early
detection and treatment. Although this is a finding that deserves a great deal more attention
(subsequent studies are currently underway), attributing the observed variation to health care
factors would be premature.
1

B. Methods Issues
Data from the IHS inpatient data system appear to be useful in generating estimates of
. incidence of cancer among AIl AN populations. Breast cancer rates among Indian women in
Arizona and New Mexico derived from extensive chart review confirmation of data from the New
Mexico Tumor Registry compare favorably with those derived from the IHS Inpatient Data
System. This is encouraging in light of the substantial commitment ofresearch resources to using
existing data sets to improve our understanding of the morbidity and mortality rates among AIl
AN communities that are attributable to chronic disease.
The documentation of screening in the medical record continues to be a problem for studies of
cancer screening. The study of breast cancerreportedinSection VII found that only43% of women
had a clinical breast examinations performed during the previous five years. On the other hand,
the study that reviewed medical records that included thePeC encounterform observed 64% with
a clinical examination during the previous three years. It is unlikely that there is this much
difference in the practice patterns of the primary providers and much of the difference is attributed
to variation in provider documentation. The PeC encounter form has a check box for breast exam
that is believed to encourage documentation of tasks done. This is a discouraging finding for
investigators hoping to obtain accurate data on breast examinations from the standard medical
record.
The study on rates of cancer in women reported in Section ill reports 95% confidence intervals
for the rate estimates. For many IHS areas the confidence intervals are wide, but are even wider
for rates reported for specific tribes. These rates are based on six years of inpatient data and it is
interesting to note that the rates reported in the breast cancer study (Section VII) report narrower
confidence intervals for two of the same tribes based on nine years of observation. Future studies
that attempt to estimate incidence rates for specific tribes would be advised to use an 8 to 10 year
time frame, if possible.
C. Patterns of Care

Study of the performance of the health care system for cancer screening in women suggested
that the major deficiency lies not in a failure to bring women infor screening, but rather to complete
the screeiiing after contact had been made and the need for screening recognized. The low
completion rates for referral and appointments to a special women's clinic raise serious question
about the value of such an arrangement. While the appropriateness of completing cancer
screening by female providers is not argued, the data from this site suggest that requiring a
separate visit for women's clinic may provide an opportunity for procrastination for those women
less than fully enthusiastic to participate in a Pap smear and breast examination. Further study
of the impact of separate women's clinics is underway.
IHS policy has been greatly influenced by a recent study from the New MexicoTumor Registry
reporting that cancer is generally diagnosed in American Indian women at a more advanced stage
and survival experience of Indian cancer patients is worse than non-Indian, even when corrected
for later stage at diagnosis. The data used in the decision model of Section VITI confirm both of the
these findings for breast cancer in Indian women in Arizona and New Mexico, but suggest that a
disproportionate share of the adverse cancer experience occurs in the numerically large Navajo
2

Nation. Figure 1 shows the distribution of stage at diagnosis for Navajo women compared to all
non-Navajo Indian women in Arizona and New Mexico. Figure2 compares the probabilityof five
year survival by stage at diagnosis for Navajo women, non-Navajo Indian women, and all women
reported by the SEER program. In both cases the experience of Navajo women appear to be
substantially worse than that of other Indian women in the Southwest. A separate study is
underway to examine further this disparity, and the implications for clinical policy in the
Albuquerque, Phoenix, Navajo and Tucson Areas oflliS. Similarly, the study reported in Section
vn provides evidence that the distribution of breast cancer stage at diagnosis of non-Navajo
Indians in Arizona and New Mexico is comparable to that observed in hispanic patients in New
Mexico. Thus, it is suggested that much of the adverse cancer experience among American Indians
reported from theNew MexicoTumor Registry is due to the experience of theNavajo. Two studies
are currently underway to followup on this suggestion.
D. Implications for Clinical Policy

The analysis of policy options for breast cancer screening reported in SectionVII suggests that
for a given population the cost of screening is 15% higher for mammography compared to a
strategy of clinical breast examination, but results in a 20% reduction in breast cancer deaths over
the first five years of the program. This compares to an 8.1 % reduction in deaths with a strategy
that relies on clinical breast examination as the screening test.
Since the rates of breast cancer are relatively low in most lliS areas an analysis was made of
the effect of varying incidence on the cost and effectiveness ratio of breast cancer screening
strategies. Interestingly, this analysis suggests that both costs and deaths prevented are sensitive
to changes in baseline incidence in the population and that the cost-effectiveness relationships are
less favorable in the range of incidence common in most AIl AN communities.
The analysis also examined the relative impact of improving stage at diagnosis (through
improved screening) compared to the impact of improving stage-specific survival (through case
management strategies). When applied to the age-sex structure of the Navajo Nation, the results
suggest that reductions in mortality comparable to those achieved by improved screening, could
also be achieved through case management strategies that improved the stage specific survival.
Even greater reductions (nearly 60%) in mortality could be achieved through combinations ofboth
screening and case managment. Important and equally dramatic effects are also seen for other
Indian populations in the southwest. This finding emphasizes the pitfall of developing a
preoccupation with a single strategy for improving health status, when multiple strategies may
be needed to achieve substantial gains.
Several of the studies suggest that failure to diagnose cancer in its very early stages appears to
be in large part dependent on patient behavior. In study of screening for cervical cancer (Section
IV), the major drop-out point in the process of care appears to be after a visit has been made and
the need for a Pap smear has been recognized. Often this is planned during a separate visit,
although an alarming number of women do not keep their appointments, even after multiple
referrals and rescheduling of appointments. In the study of breast cancer screening reported in
Section W, a substantial number of women were found to have discovered a breast lump, but
delayed examination by a physician for up to 18 months. This was particularly apparent in post
menopausal women and in women with late stage tumors at diagnosis. These findings suggest
3

Figure 1: Distribution of Stage at Diagnosis. Stage is expressed according to TNM
criteria at the American Joint Commitee on Cancer.
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Figure 2: Survival at Five Years for Breast Cancer by Stage of Diagnosis.
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2Reported by Levin et aI, ref. 13
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the need for intervention strategies that encourage women to becomeknowledgeable about cancer
and to accept responsibility for their screening. Finally, in questioning rns providers about their
perceptions of how improvements in cancer control might be accomplished (reported in Section
VI), there was a strong suggestion that the relative difficulty in improving screening rates could
be traced to an inadequate understanding of cancer and its prevention on the part of women in the
community.
A substantial body of work is underway to develop an instrument to measure patient
knowledge, attitudes, and self-reported behaviors (KABs) regarding breast and cervical cancer.
Since this work is still in progress, the brief report in Section V simply reports the status of the
developmental effort. The eventual ability to assess KAB factors related to observed behaviors
(e.g. failure to return for a visit scheduled to complete an annual Pap smear, failure to participate
in a screening mammography program, etc.) will provide addition and critical information for
program designers, program managers, and those involved in creating and modifying clinical
policy for the IHS and tribal health programs.
The study ofbreast cancer reported in Section vn describes a worrisome level ofconfusion over
priorities for mammography at the local level. First, there appears to be confusion over the use of
mammography as a screening test (applied to women with no signs or symptoms of disease)
versus its use as a diagnostic test (applied to a woman with a documented breast mass). Cases were
discovered in which a woman with a documented breast mass was put in the CHS queue, with a
resulting delay that may have permitted advancementofthebreastcancer. Clearly,mammography
for a known lesion is a diagnostic rather than a screening procedure, and local policies that confuse
the two separate functions of mammography are ill-conceived and inappropriate. Second,
priorities canbe established for screening as a function of known risk factors. For some risk factors,
such as a history of breast cancer in a first degree relative, screening mammography should be a
high priority for CHS funds. At the very least each program can specify those risk factors that
deserve screening mammography, judged in part by the estimated incidence of breast cancer in
that population.

6

II. INTRODUCTION
A. Background

The Indian Health Service continues to face enonnous challenges in assuring' adequate
primary health care services to the American Indian and Alaska Native (AIl AN) communities.
Since 1955, however, the profile of priority health problems has shown a continuing shift from
infectious disease to chronic disease, in part reflecting changes in the general living conditions and
access to health services of the populations. More recently, evidence has begun to suggest that
behavioral profiles of AIlAN communities have followed patterns set earlier by the U.S.
population, including a tendency toward sedentary lifestyles, increases in dietary fat, tobacco use,
and other behavioral risk factors for chronic disease.
Fortunately, opportunities exist to develop strategies for the prev~ntion and control of the
morbidity and mortality associated with chronic illness. There has been a steady increase in the
general acceptance of the value of certain health services, and more recently a growing acceptance
of the value of preventive services among many AIl AN communities. Community-based health
programs (increasingly operated by the Tribes, themselves) have become active in a variety of
health areas, and have begun to focus on chronic disease with emphasis on the responsibility of
individuals for their own health destiny. Taken together these trends emphasize the importance
of and the opportunities to develop strategies to deal more effectively with the spectrum of chronic
illness that affects AIlAN communities.
B. The Burden of Cancer
While the overall rates of cancer in AIl AN populations are widely considered to be less than
that in the general U.S. population, the rates for certain cancer sites, including stomach, liver,
gallbladder, and cervix, exceed the national rates'. Unfortunately, our understanding of the
impact of cancer on all AIlAN communities is limited, and the frequently cited rates for cancer
inAIIAN populations derive largely from the New Mexico Tumor Registry, which includes only
AIlAN people in New Mexico and Arizona. Moreover, there is some evidence that cancer rates
may vary by ethnicity, genetic stock, geography, and cultural and behavioral factorsP,4 Evidence
for variation is spotty and is suggested from isolated studies of specific AIlAN populations
(Lanier'i.6). Thus, our understanding of the patterns of cancer incidence and mortality (and most
importantly in the variations therein) in the AIlAN communities throughout the U.S. is incom
plete.
Despite suggestions of relatively low occurence rates for cancer in general, the survival
experience of AIlAN people who develop cancer is extremely poor (SEER,). The relative'
proportions of the projected "excess" mortality attributable to behavioral risk factors, pathophysi
ology of the specific cancers, access to care (screening, diagnostic, and treatment), knowledge and
attitudinal factors affecting both personal care patterns (e.g., BSE, smoking) and care seeking
behavior are not entirely clear. It is likely, however, that each of these may in some populations
contribute to the excessive and avoidable cancer mortality. Also, a clear and consistent relation
ship has been demonstrated in non-AllAN populations between socio-economic status and
cancer stage at diagnosis as well as with survival corrected for stage at diagnosis. 8•9
7

C. Cancer of the Breast and Cervix

There appears to be a particular margin of avoidable mortality in the case ofcancer of the breast
and cervix, since early detection can lead to virtual cure. There are several widely held beliefs
about the patterns of these two cancers in All AN women, based largely on a single data set that
describes cancer in Al women in New Mexico and Arizona. The following are often (and perhaps
erroneously) generalized to all All AN women. Compared to non-AllAN women in the U.S. it
is generally held that:

• All AN women experience a relatively lower risk for cancer of the breast, and a relatively
higher risk for cancer of the cervix (SEER).
• Cancer of the breast tends to be detected. at later stages in All AN women (Samet10).
• Suivival following breast and cervical cancer is much poorer for AIl AN women, even when
cori-ected for the later stage at diagnosis (Samet).
D. Policy and Operational Issues

In order to reduce the excessive mortality due to these two cancers, the Indian Health Service
and Tribal Programs need better information with which to plan effective emphasis programs.
Research is needed. in this area to examine the causes for avoidable morbidity and mortality with
particular emphasis on developing information for intervention strategy development and
implementation.
\
The current policy issues differ slightly among the two cancer areas. Mortality. due to both
cancers is preventable, principally through early diagnosis and treatment. For cervical cancer, the
Pap smear is widely recognized as cost-effective for early diagnosis, yet there is universal
difficulty in reaching the at-risk population with annual screening. For cancer of the breast there
are three strategies (Le., breast self-examination, physician examination, and mammography) for
early diagnosis, and debate continues on the most cost-effective strategy or 'combination of
strategies for early diagnosis among AIlAN women.
E. Study.:.Questions
This series of studies was designed to further develop an information base to support rational
clinical policy for the prevention of avoidable cancer mortality in AIlAN women. Seven specific
study questions are addressed. These include:

1. Does the incidence of cancer of the breast and cervix vary by major tribal group and by IHS
geographic area? While most studies have generalized from observations of cancer rates in
American Indian women in New Mexico and Arizona, it is possible to estimate population
rates from existing IHS data sets. Understanding variation in cancer rates is importantboth
in focusing appropriate interventions, as well as in understanding the determinants of
avoidable mortality. Baseline estimates of population rates may also assist in evaluating
intervention strategies that are subsequently developed and tested..
8

2. What is the pathway to diagnosis ofbreast cancer? Late diagnosis of breast cancer represents
a remediable deficiency in the system of health care for All AN women. Understanding the
relative contribution cancer diagnosis of both patient and system factors will greatly
facilitate development of strategies for diagnosis at early stages.

3. What are the characteristics of the patients who were diagnosed with late stage breast tumors,
compared with patients diagnosed with early stage tumors? Understanding the risk factors
associated with late or delayed diagnosis of breast cancer will suggest target groups for
screening emphasis.

4. What are the risk factors for breast cancer in American Indian women? While there is much
known about the risk factors for breast cancer in non-Indian women, there is virtually no
evidence to confirm the same risk factors in All AN women. Although the incidence of
breast cancer is less than in the general female population of the U.S., many of the
established breast cancer risk factors are thought tobe relatively more frequent in American
Indian women. This study will examine for Indian women the strength of the association
of known risk factors as well as other factors potentially predictive of breast cancer in All
AN women. In addition, this study examines the availability of risk factor data in the
patient medical record.

5. What are the patterns of knowledge, attitudes, and behaviors of American Indian women about
cancer of the breast and cervix? In order to better adapt the clinical approach of the IHS and
Tribal programs to the early detection of breast and cervical cancer, it is important to
understand the knowledge, attitudes, and (self-reported) behaviors of American Indian
women regarding the preventive and early detection strategies, and toward the personal
behaviors that can enhance both prevention and early detection for these cancers.

6. What are the patterns ofbeliefs, knowledge, and attitudes ofthe physicians about cancer of the breast
and cervix? It is important to examine factors to which IH5 providers ascribe the often seen
patterns of late or delayed diagnosis and lack of adequate follow-up of positive screening
results?

7. What are the major strengths and weaknesses in the process ofcare for early detection of cancer of
the breast and cervix? There are a number of operational challenges in assuring adequate
screening for breast and cervical cancer. Both require screening procedures that many
women would prefer to put off, neither provide the screening results on the same visit, and
thus abnormal results require a second contact with the patient, and both require a
secondary procedure in follow-up of positive screening results. In studies of other chronic
conditions, it is not surprising that a large number of individuals are screened positive and
subsequently fall through the cracks in the system of care. 11•12 By carefully studying the
dynamics of the health care system in screening for and following up positive screens for
cervical cancer, an important body of information will be gained that will lead to effective
interventions to improve the process of care for both cancers, and perhaps for other chronic
diseases as well.

9

F. Overview of the Project Components
This study has been conducted as an integrated series of six separate studies. These include.
a case-control study of women with breast cancer that addressed questions 2, 3, and 4 above. A
population-based cohort study described the natural history of the case finding process for
cervical cancer, in turn addressing study question 7. A population-based survey of the knowl
edge, attitudes, and beliefs of American Indian women regarding cervical and breast cancer would
address study question 5. The development ofthesurveyinstrument was contracted at the request
of the rns OPEL; the contract has been let and the work is in progress as reported below. A
questionnaire survey of rns physicians examined knowledge of the current screening recommen
dations and physician perceptions of barriers to complying with those recommendations as in
study question 6. Secondary analysis of data from existing rns data sets has generated more
sPecific estimates of the cervical and breast cancer rates among relevant subsets of AIl AN
populations for study question 1. Finally, secondary data was used from both the rns and national
data sets and studies to examine the implications of different strategiesfor breast cancer screening.
Each of the component studies is detailed in the chapters that follow.

10
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III. CANCER INCIDENCE AND MORTALITY IN AMERICAN INDIAN AND
ALASKA NATIVE WOMEN: AN IHS PERSPECTIVE
A. Introduction
Although American Indians and Alaska Natives (AIl AN) are considered to be low-risk
populations for cancer compared to the general population, the impactofcertain cancer sites is out
of proportion to its occurence. For example, southwestern tribes experience excessive mortality
associated with breast cancer despite incidence rates that are one-third to one-half the rate for the
general population1. It is known that when breast cancer is diagnosed in some populations, it is
at a more advanced stage, and that survival rates are below non-Indian patients, even when
controlled for diagnostic and treatment factors? The unfavorable survival is probably due to
multiple factors, and some may be amenable to change in the patterns of care provided by the IHS
and tribeu.: programs.
Limited data are available to describe the cancer experience among AIl ANs. Most of our
knowledge of the epidemiology of cancer in Indian people comes from the New Mexico Tumor
Registry. Early studies from this SEER site suggest that cancer incidence and mortality in
southwest Indians is less than that of the general population.1 Recent studies report geographical
and tribal variations in incidence, such as higher than expected rates of cervical cancer in Pacific
Northwest Indians3, and increased rates of the nasopharynx, salivary gland, liver, gallbladder and
uterine cervix in Alaska Native women4, compared to the U.S. general population.
In order to expand our knowledge ofinvasive cancerin AIl AN women this study uses existing
data sets to describe the incidence and mortality for seven cancer sites during the 1980's. Variation
among rates by illS Area of residence and tribal affiliation are the focus of this report.
B. Methods
In order to estimate lliS Area of residence- and tribal-specific incidence rates for selected
cancer sites, cases were identified using the illS Direct and Contract Inpatient database. This data
set is managed by the Division of Program Statistics of the lliS. All IHS direct and contract
hospitals report to this system with the exception of the California Area and tribally-operated
hospitals; consequently these facilities are not represented in this report.
Each record within the Inpatient Reporting System represents a discharge rather than a unique
patient. In order to identify individual cancer patients, an algorithm was developed to unduplicate
total cancer site-specific admissions down to the individual level. Combinations of the following
demographic information were used for the unduplication process: illS chart number; social
security number, when available; community of residence; date of birth; and date of admission.
To include only newly diagnosed or "incident" cancer cases during the study period, the calender
years, 1980-1981 were used to screen out previously diagnosed or "prevalent" cases from the
cancer site-specific "incident" cohorts. For example, for each specific cancer site, a patient who
had an admission in 1982-1987, as well as admission in 1980-1981 was considered to be a
"prevalent" case and excluded from analysis. Therefore, this study's definition of an "incident"
case is an individual's first hospital admission in 1982-1987 with an ICD-~ coded discharge di
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agnosis for the following cancer sites: breast, uterine cervix, endometrium, ovary, genital, lung/
bronchus, colorecta1 and allsites (Table 1).
Table 1
ICD-9 Codes for Selected Cancer Sites
Site

ICD-9Codes

Site
Breast
Cervix
Endometrium
Ovary
Genital

174.0-174.9
180.0-180.9
182.0
183.0
179.0-184.9

Lung/Broncus
Colon/Rectum
All Sites

ICD-9Codes
162.2-162.5
162.8-162.9
153.0-154.9
140.0-195.5
199.0-~.9

233.7

Denominators used to describe the population at risk for calculati~n of incidence rates, were
based upon Service Population estimates derived from the 1980 Census.6 To correct for the ex
clusion of tribally-operated hospitals, their respective Service Populations were subtracted from
Area total populations. Most Area Service Populations were not greatly affected by these
adjustments with the exception ofNashville and Bemidji Areas, where most inpatient services are
provided by tribal programs and consequently, are not tracked by the ll-IS Inpatient Database
System. Specifically, the Cherokee ServiceUnit is Nashville's only ServiceUnit represented in the
ll-IS Inpatient System and accounts for only 25% of Nashville's Service Population. likewise, in
Bemidji the three non-tribal Service Units (Greater Leech Lake, Red Lake, and White Earth)
account for less than one-third of the total Service Population. The Portland Area's total Service
Population was believed to be a gross overestimation, due mainly to the large numbers of eligible
Indians estimated to be living in Western Oregon and Puget Sound Service Units. In order to
estimate incidence rates for Portland Area, we excluded both Western Oregon and Puget Sound
cases and Service Populations from the numerator and denominator. Table 2 lists the adjusted
denominators used in calculation of incidence rates by illS Area.
Table 2
Female Years at Risk Used in Calculation of Area-Specific
Incidence Rates, IHS Inpatient Database, 1982-1987
Female Years at Risk
217,819
168,673
160,187
41,780
127,445
22,785
508,391
551,717
255,523
139,126
53,826

Aberdeen
Alaska
Albuquerque
Bemidji
Billings
Nashville
Navajo
Oklahoma
Phoenix
Portland
Tucson

2,247,282

All Areas
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In this study incidence rates were estimated for the following selected tribes who reside in
their historical North American homelands based upon present-day lliS Area of residence:
Aleut/Alaska; Apache/Albuquerque & Phoenix; Eskimo/Alaska; Navajo/Navajo; Sioux/Aber
deen; and Pima-Tohono O'Odham/Phoenix and Tucson. The Apache tribe includes White River
Apaches, San Carlos Apaches, Jicarillo Apaches, and the Mescalero Apaches. The Tohono
O'Odham and Pima tribes were considered to be anthropologically homogenous (Le., genetically,
culturally, linguistically, and geographically), therefore, these two tribes were combined for the
purposes of this study. Numerators for tribal rates were based on tribal affiliation codes included
in the lliS Inpatient System and the patient's Area of residence at the time of the initial cancer
diagnosis. For example, a woman identified as Navajo must have also resided in the Navajo Area,
all Navajos living in other Areas were excluded from analysis. Denominators used to describe the
number of women at risk for sPecific tribes were based on 1980 Census data7,8 and the patient's
Area of residence. For example, each of the tribes are, in general, from geographically defined IRS
Areas or an aggregate of counties within specific Areas. In order to estimate the number of tribal
members within a specific Area, tribal-specific counts for counties which make up the Areas were
summed to estimate the population at risk. Table 3 shows the total female years at risk for the six
year incidence study period and lists the area of residence for each tribe.
Table 3
Female Years at Risk Used in Calculation of Selected Tribal-Specific
Incidence Rates and Area of Residence, 1982-1987
Female Years at Risk
Aleut
Apache
Eskimo
Navajo
Sioux
Tohono O'Odham/Pima

22,098
63,906
93,258
449,094
136,740
72,060

Alaska
Phoenix/Albuqurque
Alaska
NavajO
Aberdeen
Tucson/Phoenix

Average annual incidence rates were based upon six years of cases and female years at risk for
the six year study period. Rates were age-adjusted using the Direct Method with the 1970 U.S.
female population as standard. For each estimated rate, a ninety-five percent confidence interval
has been constructed and reported. 9 The confidence interval ranges reflect the observed standard
error of the estimated rate. For rates estimated with a small number of cases as the numerator
value, the estimated variance and associated standard error will be quite large. Such a situation
could result in the lower bound of the confidence interval estimate being negative. Given that
negative rates are not interpretable, a negative lower bound was truncated to zero.
The National Center for Health Statistics (NCHS) American Indian and Alaska Native
Mortality Detail Database was used to identify AI/AN women whose underlying cause of death
was ICD-9 coded to one of the selected cancers sites under study.
For the purposes of this study, certain criteria were used to determine Areas for which
mortality rates might best reflect the actual cancer-related death experience among AI/AN
women geographically eligible for services provided by the IRS. For reservation states to be
14

included in Area-specific mortality rates, the AIlAN Service Population must have accounted for
at least 80% of the state-wide total AIlAN population. For states which met the 80% Service
Populatation criteria, the total AIl AN female population was used as the denominator·in the
calculation of mortality rates regardless of DiS eligibility status. Table 4 shows the female years
at risk by DiS Area and lists states which accounted for area population estimates. For
comparative purposes, rates for the u.s. All Races Female were reported from NCHS's Surveil
lance, Epidemiologic End Results Program. IO
Table 4
Female Years at Risk Used in Calculation of Selected Area-Specific
Mortality Rates, AI/AN Mortality Detail File, 1980-1986
Female Years at Riskl

Area/States
Aberdeen
North Dakota
South Dakota

257,166

Alaska
Alaska

246,477

Billings
Montana

152,943

Oklahoma
Oklahoma

662,165

Portland
Oregon
Washington

337,596

Southwest
Arizona
New Mexico
Nevada

1,084,405

TOTAL

2,740,752

lYears at risk include total AIl AN female population living in states
regardless of IHS eligibility status.

C. Results

1. Area Incidence Rates
During the time period 1982 to 1987, 2,670 incident hospitalizations for invasive neoplasms
were identified among AIlAN women admitted to non-tribally operated direct and contract IHS
hospitals. Table 5 shows the number of cases identified for selected cancers by IHS Area.
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TABLES
Number of Incident Cases of Select Cancer Sites Identified for AllAN Women Admitted Non-tribally operated IHS Direct

and Contract Hospitals by Area of Residence, IHS Inpatient Database, 1982-1987.

.....

Ovarian

Genital

Lung
Bronchus

Breast

Cervical

Endometrial

Aberdeen

57

36

9

11

60

35

19

266

Alaska

61

33

2

14

54

48

69

338

Albuquerque

19

27

4

12

44

9

14

161

Bemidj

4

2

1

0

3

11

9

48

Billings

29

25

7

12

45

25

9

162

Nashville

6

3

1

3

8

4

4

38

Navajo

77

78

13

30

127

9

24

486

Oklahoma

137

55

33

32

128

53

84

586

Phoenix

33

35

24

15

80

16

18

264

Portland

14

9

6

6

28

7

16

115

Tucson

6

7

9

3

17

2

2

49

TOTAL

481

325

113

148

613

236

268

2,670

Area

Colorectal

All Sites

0\

Age-adjusted incidence rates based on Area of residence varied markedly among regions for
selected cancer sites (Table 6). Figures la-h show relative incidence rate differences among nIS
Areas according to type of cancer. AIlAN rates and U.S. rates are standardized to per 100,000
female years at risk and per 100,000 female population, respectively. Cautious interpretation of
observed relative differences is advised due to small numbers.
a. Breast
The overall lliS rate of breast cancer was one-third the rate for U.S. All Races Female (32.4
vs.97.0). The Alaska Area had the highest rate (59.5) while the Tucson Area had the lowest .
(15.2). The 1982-1987 rate in all Southwest lliS Areas was less than 26. It is of interest that the
three highest rate Areas (Alaska, Aberdeen, and Billings) are the Northern most regions of the
lliS, although two other northern tier Areas have relatively low observed rates (Figure la).
b. Cervix
TheoveralllliS rate of invasive cervical cancer was almost two and a half times the rate for
U.S. All Races (20.2 vs. 8.8), with all Areas exceedingtheU.S. rate. Billings, Alaska, Albuquerque
had the highest rates while Bemidji, Oklahoma and Portland were the lowest rate Areas (Figure
lb).
c. Endometrium
Cancer of the edometrium among all AIl AN women occurred at one-third the rate for the
U.S. All Races. However, the rate of endometrial cancer in the Tucson Area is strikingly high
relative to other lliS Areas and nearly equals the U.S. rate (22.1 vs. 22.6, respectively) (Figure
lc).
d. Ovary

The incidence of ovarian cancer in four lliS Areas (Nashville, Billings, Albuquerque, and
Alaska) exceeded the U.S. All Races rate while the incidence rates for the Portland and
Oklahoma Areas are markedly lower than the U.S. rate (Figure Id).
e. Genital
.The Billings Area had an incidence rate for all invasive cancers of the female genital system
substantially higher than the U.S. All Races rate. Seven areas had rates comparable to the the
U.S. rate: Albuquerque, Alaska, Nashville, Tucson, Aberdeen, Phoenix and Navajo. Oklahoma
had an incidencerate substantiallybelow the national averagefor female genital cancer (Figure
Ie).
f. Lung I Bronchus
Three Areas (Bemidji, Alaska, and Billings) had rates higher than the Female U.S. All Races
incidence rate for cancer of the lung or broncus. Aberdeen and Nashville had rates interme
diate between theU.S. All Races and illS All Areas rates. Rates from the Southwest Areas were
lowest, as were rates for the Portland and Oklahoma Areas (Figure If).
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TABLE 6
Average Annual Age-Adjusted1 Incidence Rates (per 100,000 female years at risk) and 95% Confidence Intervals2 for Selected Cancer Sites by Area of
Residence for American Indian and Alaska Native Women Admitted to Non-Tribally Operated IHS Direct and Contract Hospitals, 1982-1981
Lung
Area

Endometrial

Ovarian

Genital

Bronchus

Colorectal

All Sites

44.9
[32.5,573]

23.5
[15.3,31.7)

. 7.6
[2.4,12.8]

10.2
[4,16.4]

44.5
[32.5,56.5]

31.1
[20.4,41.8]

17.9
[93,25.5]

215.0
[187.7,242.3]

Alaska

59.5
[42.7,76.8]

28.5
[17.9,39.1]

3.4
[0,73]

14.3
[6.1,22.5]

46.8
[33.2,80.4]

52.3
[36.6,88]

85.1
[63.8,106.6]

3622
[320.4,404]

Albuquerque

20.2
[10.2,30.2]

28.1
[16.6,39.8]

15.3
[5.9,24.7)

48.8
[33.1,64.5]

11.9
[3.8,20]

19.1
[8.4,29.8]

192.1
[159.8.224.4]

17.1
[0,35.9]

8.6
[0,21.9]

10.9
[0,25]

53.7
[21.1,86.4]

42.31
[13.4,713]

21Q.4
[146.5,274.7)
223.7
[186.8,261]

Bl1Ilngs

00

Cervical

Aberdeen

Bemldj

...

Breast

Nashville

353
(0,6.8]
23
[0.7)

-

( ]

38.6
[23.5,53.7)

19.6
[18.3,45.5]

10.4
[2.4,18.4]

18.3
[7.5,29.2]

62.1
[52.8,81.8]

40.1
[23.8,56.4]

15.9
[53,26.6]

33.5
[5.5,61.5]

16.8
[0,36.6]

6.4
[0,19.3]

19.3
[0,41.6]

46.4
[13,79.8]

28.1
[0,56.1]

23.2
[0,46.8]

213.7
[1423,285.5]

83
[4.7,11.9]

167.7
[151.7,184.1]

Navajo

25.9
[19.7,32.2]

24.8
[18.8,30.9]

3.8
[1.6,6]

10.5
[6.4,14.6]

40.7
[33,48.6]

3.9
[13,6.4]

Oklahoma

29.8
[24.7,35]

11.4
[83,14.3]

73
[4.9,9.7)

6.9
[5.4,8.1]

26.2
[21.6,30.8]

11.8
[83,15]

18.9
[14.7,232]

122.8
[112.6,133]

Phoenix

18.1
[11.5,24.8]

19.3
[12.3,26.4]

11.1
[6.4,15.9]

9.0
(4,14.1]

42.8
[37.6,4]

11.1
[5.8,17.6]

13.5
[7,20.1]

156.6
[1362,177.4]

Portland

18.9
[8.5,29.3]

13.3
[42,22.5]

7.9
[1.2,14.5]

63
[0.7,12]

28.8
[17.2,40.6]

9.5
[23,18.6]

11 0.5,33.2]

1392
[111.9,186.8]

22.1
[6.4,37.8]

8.9
[0,19.6]

45.7
[21.6,69.8]

7.6
[0,18]

82
[0,19.6]

156.6
[1llJ.6,204.6]

72
[5.8,8.6]

10.4
[8.6,12.2]

39.3
[36,42.6]

18.2
[15.8,20.6]

21.2
[18.4,23.8]

188.0
[180.4,195.6]

Tucson
All Areas
US All Races3
Female

15.2
[22,28.2]

19.7
[3.9,36.6]

32.7
(29.6,35.9]

20.1
(917.7,223]

97.0

8.8

t 1970 US. Female population tilled as standard.
2SEER. 1982·1986
3SEER reports colon and rectum separately: colon/rectum
4SEER reports colon and rectum sepazrately: colon/rectum

22.6

13.5

47.9

34.4

21.8

32.4/11.44

323.4

Figures 1a-1 h: Relative Age Adjusted Incidence Rates by IHS Area of Residence for
Selected cancer Sites Among American Indian and Alaska Native Women Admitted
to Non.Tribally Operated IHS Direct and Contract Hospitals, 1982-1987
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1b) Cervical
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Figures 1a-1 H: Incidence Rates by IHS Area of Residence (Continued)

1c) Endometrium
Tucson
Phoenix
Billings

U.S. All

Races

Portland

(22.6)1

Aberdeen
Oklahoma
Nashville

I
I

Navajo

IAII Areas

Albuquerque
Alaska

1{7.2)

I
I

Bemidji

o

5
10
15
20
Cases per 100,000 Female Years at Risk

25

1d) Ovarian
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Figures 1a-1 h: Incidence Rates by IHS Area of Residence (Continued)

1e) Genital
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11) Lung/Bronchus
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g. Colorectal
Alaska Area had a strikingly high incidence of cancer of the colon and rectum relative to
national averages and other TI-IS Areas while the Tucson and Navajo Areas had the lowest rate
for these two combined cancer sites (Figure 19).
h. All Sites
The U.S. Female All Races overall invasive cancer incidence rate is substantially higher
compared to the TI-IS overall rate (323.4 vs. 188.0,respectively). The Alaska Area is the only illS
Area with an allsites cancer rate which exceeds the U.S. nationaI average (Figure 1h).
2. Tribal Incidence Rates
Tribal-specific rates varied markedly for most selected cancer sites. Table 7 shows the actual
number of cancer cases by tribe. Tribal-specific rates are shown in Table 8. Figures 2a-h illustrate
relative differences among tribes for each cancer site. Cautious interpretation ofobserved relative
differences is advised due to small numbers.
a. Breast
The Eskimo and Sioux tribes had the highest incidence rates for invasive cancer of thebreast
while the Tohono O'Odham/Pima, Navajo and Apache tribes had the lowest rates (Figure 2a).
b. Cervix
Cervical cancer incidence rates for the selected tribes all exceeded the U.S. All Races Female
rate. little variation in the occurence of this cancer was observed among the six tribes (Figure
2b).
c. Endometrium
The extremely high rate of endometrial cancer for the Tohono O'Odham/Pima Indians
living in the Tucson and Phoenix Areas is even more striking than the Tucson Area rate. No
cases ofendometrial cancer were identified during the six year study period for the Aleuts from
Alaska (Figure 2c).
d. Ovary
The highest rate of ovarian cancer among the six tribes occurred in the Apaches of Phoenix
and Albuquerque. The Apache and Aleut incidence rates were comparable to the U.S. All
Races rate (15.0 and 13.3 vs. 13.5, respectively) (Figure 2d).
e. Genital
Four of the six tribes (Tohono O'Odham, Sioux, Apache, and Eskimo) had incidence rates
higher than the U.S. All Races with the Tohono O'Odham/Pirna having the highest rate of
cancer of the female genital system (Figure 2e).
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Figures 1a-1 h: Incidence Rates by IHS Area of Residence (Continued)
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TABLE 7
Number of Incident Cases for Selected Cancer Sites by Patients' Tribal Affiliation, IHS Inpatient Database, 1982-1987

~

Ovarian

Genital

Lung
Bronchus

Tribe

Breast

Cervical

Endometrial

Aleut

4

4

0

1

5

11

12

50

Apache

11

15

3

7

27

4

3

79

Eskimo

34

20

2

6

32

24

49

197

Navajo

75

76

16

31

126

9

26

481

Sioux

42

28

8

9

48

24

13

208

Tohono
O'Odham/Pima

9

12

18

5

34

5

2

95

Colorectal

All Sites

TABLE 8
Average Annual Age-Adjusted Incidence Ratesl (per 100,000 female years at risk) and 95% Confidence Intervals2
for Selected Tribes Among American Indian and Alaska Native Women Admitted to Non-Tribally Operated IHS Direct
and Contract Hospitals, 1982-1987

~

Ovarian

Genital

Lung
Bronchus

[]

13.3
[0,84.9J

37.5
[0,131.5J

90.8
[0,231.5J

107.6
[0,263.3J

394.9
[107.8,682J

30.1
[0,70.9J

5,.6
[0,22.9J

15.0
[0,45.7]

53.5
[0,108.2J

10.8
[0,38]

8.1
[0,31.3J

179.7
[73.6,285.8J

55.9
[5.5,106.4J

29.7
[0,64.2J

4.1
[0,17.5J

11.4
[0,36.4J

48.2
[25.5,70.9J

47.2
[0,97.4J

100.6
[168.4,148.6J

379.7
[237.8,521]

Navajo

25.8
[10.3,41.3J

24.7
[9.8,39.6J

4.9
[0,11.4J

11.0
[0.5,21.5J

41.2
[21.7,6O.7J

4.0
[O,10.6J

9.2
[0,18.7]

172.4
[131.2,213.6J

Sioux

53.5
[11.4,95.6J

28.3
[0.7,55.9J

11.5
[0,32.9J

11.8
[0,31J

56.0
[14.7,97.3J

32.5
[O,66J

18.5
[O,43.9J

266.8
[172.2,361.4J

18.3
[0,49.6J

23.3
[0,59.1]

31.9
[0,70.3J

10.7
[0,35.6J

66.4
[6,126.8J

13.7
[o,43.3J

6.1
[O,29.6J

222.1
[108.4,340.6J

32.7
[29.6,35.9J

20.2
[17.7.22.3J

7.2
[5.8,8.6J

10.4
[8.6,12.2J

39.3
[36.0,42.6J

18.2
[15.8,20.6J

21.2
[18.4,21.8J

188.0
[180.4,195.6J

32.4/22.45

323.4

Tribe

Breast

Cervical

Aleut

34.9
[0,443.3J

26.1
[0,89.8J

Apache

26.9
[0,67.9J

Eskimo

Tohono
O'Odham/Pima
IHS All Areas

Endometrial
0

Colorectal

All Sites

I

US FemaleAll Races3

97.0

8.8

22.64

13.5

47.9

11970 U.S. Female population used as standard
2The lower bounds of confidence intervals which were negative havE! been truncated to zero
3SEER,1982-1986
4SEER reports corpus uteri, NOS
SSEER reports colon and rectum cancer separately: colon/rectum
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Figures 2a-2h: Relative Age-Adjusted Incidence Rates by Tribal Afflillation for se
lected Cancer Sites Among American Indian and Alaska Native Women Admitted to
Non-Tribally Operated IHS Direct and Contract Hospitals, 1982-1987
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Figures 2a-2h: Incidence Rates by Tribal Affiliation (Continued)
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f. Lung I Bronchus
The Aleuts had an incidenceoflung/bronchus cancer nearly three times that of the national .
average for All Races Females. The Eskimos also had a rate that exceeded the u.s. rate. The
three southwestern tribes (Navajo, Apache, and TohonoO'Odham) had rates less than half the
U.S. rate (Figure 20.
g. Colorectal
Both Alaska Area tribes, Eskimo and Aleut, had colorectal rates which were more than two
fold the U.S. Female All Races rate for colon cancer (Figure 2g).
h. All Sites
The all Sites invasive cancer incidence rates for the Aleut and Eskimo tribes exceeded the
U.S. Female All Races rate (394.9 and 379.7 vs. 323.4, respectively). The other four tribes had
all sites cancer rates below the national average. The Navajo and Apache tribes had overall
cancer rates below the overall IHS incidence rate (Figure 2h).
3. Area Mortality Rates
During the time period 1980 to 1986, 1,870 cancer-related deaths were identified for AIl AN
women who had resided in selected states in which at least 80% of the AIl AN population was
geographically eligible for IHS services (Table 9). Mortality rates appear to vary between AIl AN
women compared to U.S. All Races Females and across IHS Areas for selected cancer sites (Table
10). Figures 3a-hillustrate relative death rates among selected IHSAreas. Cautious interpretation
of observed relative differences is advised due to small numbers.
a. Breast
Mortality rates associated with breast cancer by IHS Area ranged from nearly one-third to
two-thirds the U.S. Female All Races death rate (27.1). Aberdeen Area had the highest
mortality rate with Portland Area having the lowest (17.0 vs. 8.1) (Figure 3a).
b. Cervix
Cervical cancer death rates for all selected IHS Areas exceeded the U.S. All Races rate (3.3)
by a factor of two to four times. Portland and Aberdeen were the respective low and high rates
Areas for mortality due to cervical cancer (6.0 vs. 14.5) (Figure 3b).
c. Endometrium
Area-specific mortality rates for endometrial cancer were all well below the national
average (Figure 3c).
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Figures 2a-2h: Incidence Rates by Tribal Affiliation (Continued)
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Figures 2a-2h: Incidence Rates by Tribal Affiliation (Continued)
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TABLE 9
Number of Selected Cancer Deaths for Selected IHS Areas Among American Indian and Alaska Native Women, American
Indian and Alaska Native Mortality Detail Database, 1980-1986.

....

w

Cervical

Endometrial

Aberdeen l

24

20

3

11

41

38

15

228

Alaska

18

16

1

8

27

49

29

232

Billings 2

15

12

1

7

24

36

5

126

Oklahoma3

71

35

10

25

77

70

73

528

Portland4

17

14

1

25

30
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12

160

Southwests

70

49

5

24

85

32

29

596

TOTAL

215

146

21

100

284

250

163

1,870

lNorth Dakota, South Dakota
2Montana
3Qklahoma
4()regon, Washgton
5Arizona, Nevada, New Mexico

Ovarian

Genital
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TABLE 10
Average Annual
Cancer Mortality Rates (per 100,000 Female Years at Risk) and 95% Confidence Intervals2
for Selected Areas Among American Indian and Alaska Native Women Residents of IHS Reservation States, 1980-1986
Age-Adjustedl

Area

Breast

Cervical

Endometrial

Ovarian

Genital

Lung
Bronchus

Colorectal

All Sites

Aberdeen3

17.0
[0,36.3]

14.5
[0,32.0]

2.6
[0.10.4]

8.5
[0,22.1]

31.0
[4.7,55.1]

Alaska

12.5
[0,28.7]

12.1
[0,29.4]

0.4
[0,2.5]

7.1
[0,21.0]

21.2
[0,44.3)

38.2
[8.2,68.2)

Billings4

16.3
[0,39.9)

13.2
[0,34.4)

1.3
[0,7.1]

9.4
[0,28.1]

28.6
[0,60.8)

47.2
[5.1,89.3]

7.0
[0,25.9]

12.5
[4.6,20.4)

6.0
[0.6,11.4]

1.8
[0,4.7)

4.5
[0,9.2)

13.4
[5.3,21.7)

12.4
[4.3,20.3)

12.9
[4.9,20.9]

93.2
[71.7,114.7]

Portland 6

8.1
[0,19.2)

5.8
[0,14.4)

0.6
[0,3.1)

13.7
[0,28.4)

15.0
[0,30.0]

13.7
[0,28.4]

7.3
[0,18.7]

87.7
[49.7,125.7]

Southwest7

11.7
[4,19.4)

8.6
[1.8,15.4]

0.9
[0,2.9)

4.0
[0,8.5)

14.9
[5.0,23.8]

6.4
[0.3,12.5]

5.4
[0,10.9]

107.0
[82.8,131.2)

12.8
[8.1,17.6)

7.8
[3.3,9.4]

1.4
[0.3.0]

6.3
[2.9,9.7]

17.2
[11.7,22.8]

16.3
[10.8,21.8)

10.7
[6.2,15.2]

117.0
[102.5,131.7]

27.1

3.3

3.89

7.7

25.2

15.4

138.4

Oklahoma S

29.6
[4.1,55.2]

12.4
[0,29,2]

173.6
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[0,49.7]
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[118.3,255.3]
158.9
[81.7,236.1)
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N

TarAL
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2The lower bounds of confidence intervals which were negative have been truncated to zero
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6Qregon, Washington
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Figures 3a-3h: Relative Age-Adjusted Cancer Mort allty Rates for American Indian
and Alaska Native Women Who Resided In selected IHS Areas, 1980-1986
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Figures 3a-3h: Age-Adjusted Cancer Mortality Rates (Continued)
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d. Ovary
The Portland Area mortality rate for ovarian cancer was nearly double the rate for U.S All
Races (13.7 vs 7.7, respectively). Death rates from the Billings, Aberdeen and Alaska Areas
were comparable to the U.S. rate (Figure 3d).
e. Genital System
AI/AN death rates associated with cancer of the female genital system exceeded the U.S.
All Races rate (15.5) for the Aberdeen (31.0), Billings (28.6) and Alaska Areas (21.2). The
remaining Areas had rates slightly below the U.S. rate (Figure 3e).
f. Lung/Bronchus
Billings, Alaska and Aberdeen Areas had mortality rates for lung/bronchus cancer which
were higher than the U.S. Female All Races rate (47.2,38.2 and 29.6 vs. 25.2). The Southwest
Areas, Okla~oma and Portland had death rates below the national average (Figure 30.
g. Colorectal
The Alaska Area death rate for colorectal cancer exceeded the U.S. All Races Female rate
for colon cancer. There was nearly a five-fold difference between the low and high rate Areas,
Southwest and Alaska, respectively (Figure 3g).
h. All Sites
Mortality rates for all cancer sites combined were higher than the U.S. All Races Female rate
for the Alaska, Aberdeen and Billings Areas, while Portland, Oklahoma and Southwest Areas
had rates below the national average (Figure 3h).
D. Discussion
Several findings in this investigation invite further research. Limitations of the study method
will be discussed first and then key findings will be addressed.
1. Limitations
This study used existing data in order to estimate the incidence of selected cancers among AIl
AN women admitted to non-tribal IHS Direct and Contract Hospitals, as well estimate the cancer
related mortality for AIl AN women who resided in a subset of reservation states for which IHS
has a responsibility for providing health care services.
Other investigators have examined hospital discharge data to estimate the incidence of
cancer. ll,l2,13 In general, they have found inpatient records to be quite accurate measuring the
incidence of certain cancer sites and age groups. Unlike the hospital discharge data from which
conclusions were drawn in the above mentioned studies, the IHS data base is unique in that
admissions can be unduplicated down to an "incident" admission. This important advantage over
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Figures 3a-3h: Age-Adjusted Cancer Mortality Rates (Continued)
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Figures 3a-3h: Age-Adjusted Cancer Mortality Rates (Continued)
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other inpatient record systems such as the National Hospital Discharge Survey (NHDS) and the
Commission on Professional and Hospital Activities-Profession Activity Study (CPHA-PAS)
further bolsters ourconfidence that the ll-IS Inpatient Data Base can be valuable in the surveillance
of cancer trends among AIl AN who use ll-IS medical services. However, because hospital
discharges may reflect various local factors, including health care policies, diagnostic patterns,
treatment modalities and reporting practices, interpretation of rates should be made with these
limitations in mind.
The problems associated with using information gleaned from death certificates for
epidemiologic study have been documented.14 A unique problem associated with using existing
data for determining the health status of the AIl AN people is the accuracy of racial classification
reported on death records. The extent to which misclassication of race underestimates the burden
of mortality among the AIl AN people is presently unknown, but is thought to vary from state to
state (Personal communication: Steve Helgerson MD, MPH,Senior Epidemiologist for the Billings
and Portland illS A r e a s ) . 
Since it is not possible to distinguish deaths for AIl AN women based on where they received
medical care He., illS vs. non-illS facilities), mortality rates include all women identified as AIl
AN regardless of primary source of medical care. The study method used attempted to control
for this situation by calculating Area mortality rates exclusively for states with at least 80% of the
total AIl AN population being geographically eligible for medical services provided by the IHS.
Reported rates for incidence and mortality were based upon population estimates derived
from the 1980 U.S. Census. Recent review of the IHS Patient Registration System indicated that
the Census-based Service Population counts may actually underestimate the populations at risk.
Presently, the extent to which these two population counts differ is unknown. Therefore, the rates
reported in this study may be inflated to some unknown degree. Further investigation into this
issue is critically important to future health status research within the illS.
Readers need to realize that caution should be exercised in the interpretation of estimated rates
and their associated confidence interval. Given that small numbers do come into play in the
estimating of some rates (Tables 5,7), the observed variance and standard error of the rate can be
relatively large. Therefore, large relative differences between Areas and I or tribes may not be
statistically significant.
2. Key Findings
For each of the cancer sites studied the Overall rns rate was below the rate reported for U.S.
All Races. However, marked variations among ll-IS Areas were observed and for various cancer
sites certain rns Area rates were above the U.S. rate.
The North (high rates) to South (low rates) geographical variation in the occurence of breast
cancer are consistent with previous regional studies.2.3.4,15.16 The overall illS mortality associated
with breast cancer, based on selected Areas, was 12.8 per 100,000 female years at risk. Funk
reported a similar rate, 12.1, for the years 1974-1983}5 Although the Alaska Area had the highest
incidence of breast cancer, the Area mortality rate was below the average IHS rate. Unlike Alaska,
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the Aberdeen and Billings Areas had both high incidence rates and mortality rates associated with
breast cancer.
The IHS rate for invasive cervical cancer is more than double the rate for the U.s. All Races.
Other investigations have observed high rates ofcervical among Indian women, alsO.3,4.17.18 Alaska
had the highest incidence with the third highest mortality associated with cervical cancer.
Aberdeen Area was ranked third for incidence and had the highest mortality rate for this cancer
site.
Although the overall occurence of endometrial cancer in the IHS was one third the national
average, the high rates observed for the Tucson and Phoenix Areas were striking. This finding
invites further investigation in order to identify risk factors associated endometrial cancer for
Indian women living in southern Arizona.
.
Ovarian cancer occurred less frequently in AIl AN served by thelHS compared to U.S. all
races. However, the Portland Area was observed to have the lowest incidence of ovarian cancer
but the highest mortality associated with this cancer site.
The marked variation in the distribution of lung and bronchus cancer within the lliS appears
to be associated with smoking habits, as evidenced in the rarity of disease among American
Indians from the Southwest, where cigarette smoking is relatively uncommon, compared to high
incidence of lung and broncus cancer in Indians where the prevalence of smoking is reportedly
high (Northern Plains Indians and Alaska Natives).19
The Alaska Area women have a strikingly high rate ofcolorectal cancer relative to both the IHS
overall rate and the colon cancer rate for the U.S. All Races. This finding has been reported in other
studies, as well. 4,20
Each IHS Area has an all sites cancer rate considerably below the U.S. All Races Female, with
the disturbing exception of the Alaska Area. The Billings, Aberdeen, Nashville and Bemidji Areas
had intermediate allsites cancer rates, while Southwest Areas, Oklahoma and Portland Areas had
the lowest rates for all cancers combined.
Opportunity exists for lliS and other investigators to rePeat studies of this kind in the future
to monitor trends in the occurence of cancer among American Indian and Alaska Native PeOple.
As future studies focus on "potential explanations" for the findings herein-the "qUality" of data
and interpretative possibilities may improve.
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IV. PAITERNS OF CARE OF BREAST AND CERVICAL CANCER:
PERFORMANCE OF THE HEALTH CARE SYSTEM
A. Introduction
The incidence of cervical cancer is higher among American Indians and Alaska Natives than
for all-races U.S. women. As noted in Section III, the age-adjusted rate is 20.1 per 100,000 for Indian
women from all IHS Areas, compared to 8.8 for U.S. all-races. In contrast to the pattern of the
general U.S. population, some IHS Areas experience a cervical cancer rate either comparable with
or slightly greater than that of breast cancer. The incidence of breast cancer, on the other hand, is
lower among American Indian and Alaska Native women than among U.S. all-races (32.7
compared to 97.0 per 100,000). In both instances, death is avoidable when the malignancy is
discovered early. Early detection, however, is a function of both patient and health care system
behavior; and there is evidence that cancer in American Indians of the Southwest is diagnosed at
a later stage and associated with worse stage-specific survival thari-other ethnic groups of the
Southwest. 1
Previous data suggest that screening has not been very successful for either cervical or breast
cancer in the IHS population despite the existence of specific quidelines.2.3 A number of solutions
have been proposed including more specially designated women's clinics, education (and
exhortation) of providers, non-physician screeners and screening mammography. In order to
select wisely among the variety of possible solutions, iUs necessary to clearly understand the
current impediments to adequate screening.
We have made cervical cancer screening the principal focus of this study, but because the two
procedures are so frequently done on the same visit, breast cancer screening has been examined
incidentally. The method used was developed in the Indian Health Service to examine the health
care system behavior,4,s,6,7 and has demonstrated its value in identifying remediable deficiencies
in performance of the health care system. This approach has been used in this study to examine
the performance of the health care system for early detection of cancer of the cervix and breast.

B. Study Site
Approximately 11,471 Tohono O'Odham people live on or near their 2,855,874 acre reservation
in rural southern Arizona. 8 The Sells Service Unit of the IHS provides health services to the T.O.
as well as other Indian people living in the area. A 37-bed hospital and outpatient department are
located in the community of Sells, located 60 miles west of Tucson. The Service Unit also operates
two full time ambulatory care centers, one located 30 miles to the northwest of Sells (Santa Rosa
Clinic) and the other east of Sells in the suburbs of Tucson (San Xavier).
The study site is more or less typical of a reservation-based program; two of three clinic
locations have a women's clinic. A patient may have separate medical records at all three clinics.
In practice, however, it is more usual for a patient to obtain the bulk of her care at one location.
However, since the hospital is located at Sells, many San Xavier and Santa Rosa users also have
active records at Sells. Because San Xavier is located near Tucson, some of the Tucson patients use
both the IHS clinic and other local providers.
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Care at the three clinic locations is provided five days a week between about 8:00 A.M. and 5:00
P.M. The Sells Hospital has an emergency room. Within these clinic hours, most patients are seen
in general, walk-in clinics. However, during the week, half-day clinic sessions are reserved for
special types of patients such as chronic disease, well-child, prenatal and "women's" clinics. Sells
and San Xavier have pharmacies; medications are dispensed by the provider at Santa"Rosa.
Pap smears and clinical breast examinations are done at all three locations, and all specimens
are interpreted at the Phoenix Indian Medical Center. Results are returned directly to the clinical
facility of origin for inclusion in the patient's record. Patients from all three sites, whose results
are abnormal, are usually contacted and referred to Phoenix for colposcopy or followed clinically
until a normal Pap result is obtained. At the present time, a clinician at one site would nothave
access to the date and result of a Pap smear accomplished at one of the other facilities.
Since the early seventies, the Service Unit has been associated with the development of a
pioneering automated patient care data system. The current version of this system is called the
Patient Care Component (PCC) of the Indian Health Service's R~urce and Patient Management
System (RPMS). A part of this system is an encounter form that is used both as the record of the
patient visit and as the data entry form. The form is structured to make it easy for a provider to
order a Pap smear or a breast exam and also to refer a patient to another clinic or provider.
The Service unit has also served as a developmental site for a method of. ambulatory care
managment, called "industrial strength triage". During the study period this process was in
operation for general or walk-in clinic sessions at two of the locations. In order to recognize and
respond to a range of patient needs for service, part of the triage process requires review by the
nurse-triager ofa patient's record at thebeginning of theencounter. This includes recognizing and
arranging for needed Pap smears on that visit or making a subsequent appointment-:-eften to the
"women's clinic". The patient herself is responsible for the actual scheduling of a subsequent
appointment.
The Tohono O'Odham users of the Service Unit are primarily reservation residents (80%);
other tribal members live inTucson orin other small communities in the vicinity of the reservation.
Forty-six percent of the population (11,471) is under age 20.8
C. Methods

. This study examined system performance from three perspectives. The first was population
based; screening rates for age-risk groups were calculated. The second perspective examined
specific patient-eontacts with the health care system (contacts representing opportunities for
screening) and computed theprobability that a screeningexamination was done. This perspective
also examined the probabilities of recognition of need for screening as well as the probabilities of
completed screening. By disaggregating the data by certain characteristics of the patient
encounter (e.g. clinic type, provider of service, time of day, etc.) additional information was
collected. that describes strengths and weaknesses of the system. The third perspective examined
the process of care as a sequence of events involving patient contact, recognition of the need for
screening, and accomplishment of the screen. Findings from this perspective computed the
proportion of patients that failed or passed successfully through each screening step.
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The study population was defined as those women who a) were twenty years old or over in
1988, b) were members of the tribe and c) had at least one visit or encounter with the Service Unit
in 1986-88. This screening-eligible population numbered 3,637 women and a random sample of
200 women was selected using the automated data system. During the subsequent data analysis,
the number of individuals in the age group over 65 years was enhanced in order to more
specifically examine system performance for three age groups (20-39,40-64, and over 64 years).
Women were excluded from the sample if they had a hysterectomYi were under treatment for a
previous abnormal Pap,or ifduring chart review there was evidence that they were receiving most
of their health care from sources other than the Sells Service Unit. Table 1 shows the number of
women sampled and number of women included in the study by age group.
Table 1
Distribution oof Sample
Age Group

Sample Selected

Population

Final Sample

20-39

2066

114

96

40-64

1183

66

42

378

20

46*

3627

200

65+
Total

184

It'fhis number was originally 20 and was enhanced as described in order to examine the care
patterns of this age group.

Manual chart review of each separate medical record (up to three) for each woman in the study
cohort was completed to assemble a data set that described the women and their contacts with the
health care system. As shown by the data collection protocol of Figure I, specific data elements
included demographic information, date and results of last Pap smear and breast exam, the date
the next Pap smear and breast exam were due (based on the one year guideline). Additionally, data
were collected on each visit made while a Pap smear was due in order to describe the patient and
provider.contributions to successful screening.

In the analysis both cervical cancer screening (Pap smear) and a clinical breast examination
were considered to be due each year for all women in the study cohort. This is consistent with the
lliS standard of care, even though the national guidelines suggested by the American Cancer
Society (1980) are less stringent for cervical cancer.
D. Results
Table 2 shows the proportion of the study cohort up-to-date for cervical and breast cancer
screening as ofJanuary 1989. The overall one-year screeningrate was 38% for Pap smears and 36%
for clinical breast examinations. Three year rates were also calculated for comparison with other
studies. The annual screening rates achieved were not impressive and the rates vary inversely
with age (and with risk of breast and cervical cancer). The rates for breast examination compare
closely with Pap smear rates, presumably because the two are often performed at the same time.
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Figure 1
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PAP ORDERED
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NEED FOR BE RECOG
BE ORDERED
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MAMM ORDERED
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Table 2
Screening Status of Sample as of January 1, 1989

Age Group
20-39
40-64

65+
Overall'"

Pap Smears
(Up-to-date
screened in 1988)
45% (43/96)
33% (14/42)
15% (7/46)
38%

Screened in
last 3 years
75% (72/96)
52% (22/42)
43% (20/46)
65%

Clinical Breast Examinations......
20-39
40-64

65+
Overall'"

40% (39/97)
36% (17/47)
17% (8/48)
36%

74% (72/97)
49% (23/47)
46% (22/48)
64%

·Weighted. average based on stratified. sample
"The denominator for clinical breast examinations includes women who
were excluded. from the Pap screening denominator because they had
a hysterectomy.

In order to better understand the system factors that contribute to the low screening rates, we
first calculated the probability of being screened, given that the patient made a visit when the
procedure was due. Thus, visits made when due for screening represent screening opportunities
and Table 3 shows the rate at which the system capitalizes on such opportunities. The women in
the sample made a total of 678 visits when due for screening. Given a screening opportunity, the
youngest age group had a better chance of being screened (17%) than the 35-64 year olds (7%) or
the 65+ group (5%). Interestingly, the older age group made the largest number of visits per patient
(6.1) when due for a Pap smear, compared to 4.1 and 2.3 for the 40-64 and 20-39 year olds,
respectively. Thus, although the older age group offered the largest number of screening
opportunities, the probability of being screened on any given opportunity was the lowest of three
age groups. The percentage of encounters at which a Pap was done and the percentage at which
a breast examination was done are quite similar, again suggesting that both procedures are often
done concurrently. For example, during 1989 the women in the sample had a total of 65 Pap
smears; on 86% of these visits breast examinations were also done.
Table 3
Probability of Getting a Needed Pap or Breast Exam
Age Group
20-39
38/222
40-64
13/174
65+
14/282

17%
7%
5%

Breast Examinations
Age Group
14%
20-39
32/224
8%
40-64
16/197
15/292
5%
65+
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Successful screening requires three steps-contact when due, recognition of need, and doing
the screening procedure, a Pap in this instance. Using specific visits as the unit of analysis, each
of the three steps were examined separately. Table 4 shows the distribution of contacts (when
screening was due) by clinic type and by age group. It is clear that most of these contact
opportunities occur in the general clinic (over 50% for all age groups); chronic disease clinics
present important opportunities for the 35-64 age group and contact with the pharmacy (presum
ably for medication refill) represents an important opportunity for the group 65 and over.
Women's clinic appears to offer screening opportunities mostly in the youngest age group
consistent with the provision of prenatal care in women's clinic. In the older age group women's
clinic only offers 3% of thescreening opportunities, and would thus appear to play an insignificant
role in cancer screening for the older woman.
Table 4
Distribution of Opportunities for Screening by Age Group and ainie Type
Age Group
20-39
Total
Encounters

General
Clinic
55%
(122)

Emergency
12%
(26)

Pharmacy
5%
(12)

Women's
Clinics
14%
(31)

Chronic
Disease
4%

Other"
10%

(9)

(22)

16%
(27)

11%
(19)

11%
(30)

(29)

222

40-64
Total
Encounters

52%
(91)

6%
(10)

8%
(14)

7%
(13)

174

65+
Total
Encounters

51%
(143)

7%
(20)

18%

(52)

3%

(8)

11%

282
-opthalmology, optometry, physical therapy and podiatry

Table 5 shows the rate (by clinic type) at which the need for screening was recognized, given
a screening opportunity. Recognition of need consisted of either doing the Pap at that visit or
indicating that the woman should make an appointment to women's clinic. Women's clinic has
an excellent rate of recognition (and completion) for all three age groups, but the contacts
occurring at womens'clinic represent less than 10% ofall screening opportunities for the two older
age groups. Women's clinic represents a higher proportion of encounters for the 20-39 year age
group, probably because of the frequency of prenatal visits in this age group. The relatively high
rate of recognition from the general clinic for the 20-39 year age group may be due in large part
to recognition of pregnancy rather than recognition of need for cancer screening per se. Recog
nition of need is poor for the 40-64 group and the 65 and over group in general clinics, but is better
for these women in the chronic disease clinics. Pharmacy contacts do not often result in
recognition of need, however, the fact that need is recognized occasionally suggests that
pharmacy visits are a possible point of recognition.
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Table 5
Probability of Having Need Recognized,
Given Opportunity for Screening Pap Smears -1989

Age Group

General
Clinic

Emergen~

Clinic Type
Women's
Dinic
Pharma~

Chronic
Disease

Other

Totals
~

20-39

48%
(59/122)

4%
(1/26)

8%
(1/12)

74%
(23/31)

56%
(5/9)

40-64

27%
(25/91)

0%
(0/10)

7%
(1/14)

100%
(12/12)

56%
(15/27)

0%
20%
(0/19) (53/174)

17%
(25/143)

5%
(1/20)

2%
(1/52)

100%
(8/8)

43%
(13/30)

14%
0%
(0/9) (48/282)

Totals
40%
(Clinic) (109/274)

3%
(2/56)

4%
(3/78)

84%
(43/51)

50%
(33/66)

0%
28%
(0/69) (190/678)

65+

40%
0%
(0/22) (89/222)

"Includes opthalmology, optometry, physical therapy and podiatry.

Once contact has been made and the need for screening has been recognized, only the
performance of the Pap smear remains for successful completion of the screening. This may occur
during the visit at which the need was recognized, or the woman may be offered a return·
appointment or an appointment to women's clinic, the latter being the predominant pattern in the
study site. Table 6 shows the rates at which Pap smears are done, given contact and recognition
of need for the major clinic types. Clearly, the women's clinic performs best, yet the overall rate
at which Pap smears are accomplished, given contact and recognition is only 34%. As noted above,
recognition of need at the chronic disease clinic is relatively high, but completion of the procedure
is very poor.

Table 6
Probability of Getting Pap Done, Given Recognition of Need

Age Group
20-39

65+

Totals

General
Clinic

Clinic Type
Chronic
Disease
Emergency

Women's
Clinic

Pharmacy

Totals

22%
(13/59)
4%
(1/25)
24%
(6/25)

100%
(1/1)
0%
(0/0)
0%
(0/1)

20%
(1/5)
0%
(1/15)
0%
(0/13)

100%
(23/23)
100%
(12/12)
100%
(8/8)

0%
(0/1)
0%
(0/1)
0%
(0/1)

43%
(38/89)
25%
(13/53)
29%
(14/28)

18%
(20/109)

50%
(1/2)

3%
(1/33)

100%
(43/43)

0%
(0/3)

34%
(65/190)
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Having examined the performance of the health care system in achieving patient contact,
recognizing the need for screening, and completing the screening procedure, a continuity
sequence can be used to examine the impact of this pattern of system performance on the
probability that a given woman will be successfully screened. It is useful to examine the flow of
patients through the three steps of the process. The results are shown in Table 7 and Figure 2.
Oearly the major dropout point is between recognition of need and completion of screening, both
as the relative deficiency as well as in absolute numbers. Of those women who dropped out of the
process of care (n=119), 42% do so after contact and recognition. These findings reinforce the
suggestion that contact with the system and recognition of need are the relative strengths of the
system, but completing the Pap smear (often requiring a separate visit to women's clinic) is the
relative weakness.
Table 7
Probability of Receiving a Pap

Age Group
20-39

96

73%
(70/96)

80%
(56/70)

68%
·(38/56)

40-64

42

100%
(42/42)

74%
(31/42)

42%
(13/31)

65+
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91%
(42/46)

50%
(28/42)

50%
(14/28)

184

84%

75%

57%

All Ages

% Making
Contact

Of Those Who Of Those Who .
Made Contract Were Recognized.
% Recognized
% Screened

Number
In Group

E. Discussion
A comparison of these population-based screening rates with data from other studies dem
onstrates similar results. A recent project on theNavajO Area oflliS2 found that 40% of the women
had been screened in the past year, compared to 38% in this study. Data from the National Health
Interview Survey in 19873 reported 56% having had a Pap in the previous year. This survey also
reports that this rate drops to 48% for women with an annual family income of less than $10,000;
on the local reservation, 50% of those who could be in the labor force are unemployed and 62% of
the individuals who are employed earn less than $5,000 per year.8 The NavajO study reported that
64% of their subjects had received a Pap in the past three years as compared with 68% in this study.
The NffiS, 1987, reported that 88% of women surveyed said they had had a Pap at some time.
Examining the steps in the process of care for cervical and breast cancer screening reveals that
a lack of contact is not the reason behind the low screening rates. Eighty-four percent of the sample
made contact with the health care system at a time when a Pap was due. Since less than 50% of
those who made contact were screened, mounting an outreach effort to bring more women in
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FIGURE 2: Probability of Success - Cervical Cancer
Screening, Sells Service Unit, 1989

Study Cohort
Women Eligible for Screening
n=l84

No 16%

>--.... DropOut
0,"_"

No 25%

>----.... Drop Out
n=39

No 43%

>-_.... Drop Out
n=50

SCREEN RATE
38% (65/184)

50

contact will not be productive unless the system can improve its ability to complete a Pap, given
that the patient has made a visit.
Recognition of the need for screening was not remarkable. In the youngest age group, this
recognition may often have been recognition of pregnancy rather than recognition of need for a
Pap smear. In the older age groups, recognition often occurred in the chronic disease clinics
(especially diabetic clinic) where the procedure was almost never performed.
Women's clinics are becoming popular in the llIS as a strategy to increase cancer screening.
However, these data suggest that separate women's clinics may have only minimal effect on the
overall screening rates of a community although they perform well for the women who use them.
Unfortunately, only a small proportion of the total population at risk use the women's clinic. The
women in this study cohort were referred to women's clinic a total of 125 times, but made only 23
visits in response to the referrals. Table 4 suggests that the cohort o(women actually made 52
contacts with women's clinic, the difference being in those women who were self-referred to
women's clinic. Thus, women's clinic appears to meet an important need for those women who
choose to use it and are self-referred, but the need. for a separate return visit provides an additional
opportunity for a patientwho may be ambivalent about cancer screening to drop outof the process
of care. The Sells Service Unit has recently modified the notion of a women's clinic, replacing the
separate clinic session with a female provider available during all clinic sessions for cancer
screening and other female health promotion services.
Work is currently underway to follow up on several interesting results of this study. In
particular, the characteristics of both the patients and the encounters at which screening is
successfully accomplished will be compared with the characteristics of patients and encounters
at which opportunities for screening were missed. Also a more detailed study of the impact of
women's clinic on cancer screening rates in the population will be examined. This work will be
reported at a later time.
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V. DEVELOPMENT OF AN INSTRUMENT TO ASSESS CANCER KNOWL
EDGE, ATTITUDES, AND SELF-REPORTED BEHAVIORS OF AMERICAN
INDIAN AND ALASKA NATIVE WOMEN
A. Introduction
The purpose of this project has been to develop ways to assist 'Indian health programs to
identify some factors that lead to the relatively late diagnosis of cancer of the breast and cervix
among American Indian and Alaska Native women. This knowledge will assist these health
programs to plan culturally sensitivebreast and cervical cancerinterventions for Native American .
women.
.
B. Description of the Project
Screening for breast and cervical cancer can reducemortality. Women's perceptions ofdisease,
risk and access as well as their feelings of responsibility for their own health influence their use of
screening programs. This project was designed to develop a means of evaluating these percep
tions. The information can be used by Indian health programs to design strategies to improve
screening rates, particularly among women who are at higher risk for breast or cervical cancer.
Phase I
On September 29th, 1989 the Indian Health Service contracted with Economic Development

Systems and MESA Services International to develop a survey instrument that could be used in
Native American communities. The contractor was responsible for assembling a bibliography of
past major projects that surveyed minority and lower socioeconomicpopulations regarding breast
and cervical cancer prevention. Copies of survey instruments used were obtained.
Using this bibliography and, especially, recent surveys that were funded by the National
Cancer Institute for use with minority populations, a draft questionnaire was developed. Items
were added that were believed to be of special concern to AIl AN females.
To provide guidance to the project, an advisory panel was assembled by the Indian Health
Service. The members of this panel are listed in Appendix B. The group included experts from
Universities and other government agencies as well as individuals who provide care to Indian
women (some of whom are themselves Indian). At their first meeting in December of 1989, this
group reviewed the initial draft instrument, suggested changes and strongly recommended that
the contractor spend more time in Indian communities developing the instrument. They
specifically suggested that the contractor work with age specific "focus" groups of women on two
reservations.
Phase II
Following a pilot test using focus groups with urban Indian women in Salt Lake City, the
contractor arranged to work with women in the Tuba City, AZ and Shiprock, NM Service Units
as well as at Ft. Duchesne, Utah. The contractor obtained permission from the Area Research and
Publication Committees and from the rns ServiceUnitsbefore contacting the specific tribal Health
Advisory Boards.
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In these focus group sessions, women had the opportunity to discuss the questions and the
language, giving the contractors the opportunity to modify the instrument on the basis of the
women's discussions. Since many older Indian women are more comfortable in their own
language that they are in English, these groups also afforded the contractors an opportunity to
evaluate the difficulties associated with translation. A total ofeight groups were completed; fifty
seven women were involved, 31 from Shiprock and 26 from Tuba City.
On the basis of these pilot tests, the contractors reworded questions that contained negatives,

reduced the number of responses (on questions that required gradations) from five to three, and
eliminated questions about likelihood ofcancer. Abstract questions were simplified and questions
about the results of screening tests were added.
The revised draft survey instrument was then used in focus group discussions with women
from the Northern Ute reservation (Uintah and Ouray), which is located near Roosevelt, Utah.
Over a.'four day period in June, the contractors held discussions with sixteen groups of women;
the agecategories were15-24,25-44,45-64 and 65+. Between five and seven women in an age group
attended a group session. In general, the group discussions for women 65+ were less well attended
and required more time due to the need for translation. The questionnaire was revised again on
the basis of these experiences and an interim report was prepared by the contractors.
In July of 1990 the advisory panel again met with the IHS Project Officer and the contractors.
The results of the field tests at Tuba City, Shiprock and Ft. Duchesne were presented and
discussed. The reasons for the focus groups were identified as:
a. Serving as an entree to an Indian community even after the instrument development and
testing phases are completed;
b. Acting as an organizing point for training community interviewers; and
c. Creating an opportunity for a local community to add to the core items, concerns specific to the
locality.
The.panel recommended that focus groups become part of the total protocol for conducting a
community survey.
Because of major differences among age groups, the panel recommended that the remainder
of the contract be devoted to testing the instrument and the interview process (selecting and
training interviewers, detailed instructions for conducting interviews, etc.) in a one-to-one mode.
Two additional field sites (different tribes) were suggested; because the initial test sites demon
strated that it is more difficult to interview older women, the panel recommended that the next
tests oversample in the older (65+) age group. This oversampling would improve the experience
with and, therefore, the instructions for administering the survey to this group of women.
Phase ill
The third phase of the project consisted of further field testing. The sites selected were two
pueblo communities in northern New Mexico and the Northern Cheyenne reservation, with
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headquarters in Lame Deer, Montana. The contractors contacted the appropriate Area research
committees in Albuquerque (NM) and Billings (MT). Mter tribal and Service Unit approval was
obtained, interviews were conducted in new Mexico in early September, 1990. Following similar
proCedures, interviews in Montana were done later that month.
In Albuquerqueand at Lame Deer, the contractors located a local coordinator who was familiar
with the Indian communities. This person was able to recruit local interviewers, make arrange
ments for training space and make preliminary preparations to identify potential respondents. In
all three communities, the contractors conducted a four hour training for the local female
interviewers to:
a. Introduce the interviewers to the purpose of the study,
b. Conduct a focus group session to gain information about the coqununity's perceptions of
health care in general and specifically those relating to knowledge, attitudes and beliefs about
cancer and cancer screening,
c. Familiarize the interviewers with the instrument and its structure, using role playing to
demonstrate how they might respond during an actual interview,
d. Assess the clarity of the questions and attempt to minimize difficulties that might be antici
pated in the administration of the questionnaire.
A result of these pilot tests has been the demonstration of the difficulty associated with using
tribal rolls as the basis for the selection of a random sample. The contractors reported that tribal
lists were available, but these lists could not be used to develop sublists of females- with date of
birth and current address, items needed to stratify the population by age and then contact them
for interviews. They reported that it would be possible to develop such lists, but that this was not
possible within the time constraints of the contract. The contractors used cluster sampling,
attempting to sample all the local communities. They did not comment on wheth~rthe technique,
which is used frequently in urban settings, can be used reliably in rural settings to obtain a random
sample of the population. In this test setting, they attempted to randomly select equal numbers
of respondents for each age group.
The results of these tests were presented to the Advisory Group in November of 1990. The
contractor had been asked to assess the clarity of the survey instrument and the acceptance of the
questions by the women. This was accomplished by asking the respondent herself if she had any
questions following the interview and asking the interviewer to complete a brief assessment of
each interview. The contractor also completed an analysis of non-responses which revealed that
there were more non-responses among the Cheyenne group than among the Pueblos and among
the older women than in the younger. About 35% of the women (both groups) completed the
interview in 20 minutes or less.
At the final Advisory meeting, the group recommended that the contractor complete his work
by submitting the final set of revised interview questions together with instructions to the
interviewer for each question. The Panel reminded the illS that in order to complete this project,
detailed plans for training interviewers must be developed as well as standardized methods for
sampling within a community, and entering and analyzing the data.
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READ Hello,mynameis
. Wearetakingasurveyforthe
(Tribel
Indian Organization/Health Corporation). We would like your help to get a better understanding
of what women here believe about cancer and cancer screening. Of special interest to women
are the cancers of the breast and of the cervix. You were randomly selected as the person in
your household to participate in the study. This interview will take about a half-hourto complete.
Your answers will be confidential and your name will not be associated with your answers. Your
cooperation is completely voluntary. You may refuse to answer any question you choose. We
really would appreciate your participation because we need to knowwhatthe women here think
about these issues. This will help a great deal in planning future health programs for women
here.
1. Will you help us? _
IF YES, GO TO 2
IF NO
Could we reschedule for another time?
Yes
,-.,
IF NO, PROBE-DON'T LOSE INFORMANT
Z"
IF YES, RESCHEDULE FOR
_
2. Time interview started
_
3. Time interview ended
4. Result of last contact:
Interview completed
---Partial interview. Reschedule for:
_
_ _ _T,erminated
_ _ _:Not Home
-=-__Refused
Date of:
5. Respondent 10#
6. Interviewer:
1st visit
7. Interviewer:
(If required) 2nd visit
_
8. Interviewer:
(If required) 3rd visit
_

No

_

EDITOR: TEAR OFF INFORMA'"ION BELOW

............................................................................
RESPONDENTS NAME:

1.0. #

~_

_

AOORESS:,

_
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1. Overall, would you say that your health now is:
Good
--Fair
_ _P,oor

2. I am going to read a list of health problems. In your opinion, which ones would you say are the
worst problems here?
_ _H,eart Disease
_--:Stroke
_ _High Blood Pressure
_-,Diabetes
Violence
--Alcohol or Drug Abuse
_ _Or Something Else?
specify
_ _Don't Kn-o-w----

' . '

3. Sometimes we learn about health problems like cancer from our relatives or friends. Has your
mother or any of your sisters, or any other female relative ever been told she had cancer?
_ _Yes
No
--Don't Know
_ _No Answer
3a. Who was it?
Mother
--Sister
_ _Other, specify
3b What kind(s)?

_

4. At what age is a woman more likely to get breast cancer?

_

5. At what age is a woman more likely to get cervical cancer?_ _
6. Have you been to a clinic or health practitioner in the last year?
_ _Y,es
_ _,No
6a. What for?

_

7. Thinking over the past year, was there anytime when you needed medical care or advice, but
you did not get it?
_ _Yes
_ _~No
_ _Don't Know
_ _,No Answer
7a. If yes, what was that?
_ _Fear that it would result in something she didn't want to hear
_ _Fear that it would result in something she didn't want to do (such as getting surgery,
shots, going into a hospital)
_ _Too busy with other things
_ _Care was not available when needed
_ _Costs too much to get there
_ _Didn't know where to go
_ _Hours not convenient
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.,

._....._-_._---~--,-,---------

_-----,Have been treated rudely in the past
_ _Waiting times too long
-Don't know
_ _Other
(specify)
_
8. If you wanted to get a check-up or physical examination from a health professional, how difficult
or easy would it be for you to get one?
_Very Difficult
Somewhat Difficult
Easy
Don't Know
No Answer
8a. Why was it difficult for you?

9. Now I'm going to read you a list of conditions. Please tell me if you would personally go to a
health practitioner if you had:
a. No appetite for 2 weeks.
Yes
-Not Sure
-No
No Response
b. Indigestion or upset stomach for 2 weeks.
Yes
-Not Sure
-No
_No Response
c. Change in bowel or bladder habits.
Yes
-Not Sure
-No
No Response
d. Urine or stools becoming darker.
Yes
-Not Sure
-No
No Response
e. Bleeding or discharge.
Yes
-Not Sure
-No
No Response

1. Unusually tired or fatigued.
Yes
-Not Sure
-No
No Response
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g. Coughing up blood.
Yes
-Not Sure
-No
No Response
h. Cough or hoarseness for 2 weeks.
Yes
-Not Sure
-No
No Response
Shortness of breath.
Yes
-Not Sure
-No
No Response

i.

Chest pains.
Yes
-Not Sure
-No
No Response
j.

k. Difficulty in swallowing for 2 weeks.
Yes
-Not Sure
-No
No Response
I. A sore that does not heal.
Yes
-Not Sure
-No
=No Response
m. Thickening or a small lump in the breast.
Yes
-Not Sure
-No
-No Response
p. White spots in the mouth.
Yes
-Not Sure
-No
_No Response

q. Changes on skin. rashes. blemishes. blotches.

Yes
-Not Sure
-No
-No Response

r. Jaundice or yellow skin.
Yes
-Not Sure
-No
No Response
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10. Now Iam going to read a list of statements about health examinations, cancer, and procedures
to find cancer early.. For each, please tell me if you agree or disagree.
. a. Having a general physical checkup once a year is worth the time and effort.
_Agree
_Not Sure/No Opinion
_Disagree
_No Response
b. It is important that people participate in health screening programs such as blood pressure
checks.
_Agree
_Not Sure/No Opinion
_Disagree
_No Response
c. Today it seems that just about anything can cause cancer.
_Agree
_Not Sure/No Opinion
_Disagree
_No Response
d. It is important that every woman examine her own breasts for any kind of change.
_Agree
_Not Sure/No Opinion
_Disagree
_No Response
e. If breast cancer is found and treated early, it can be cured.
_Agree
.
_Not Sure/No Opinion
_Disagree
_No Response

1. If a woman has a lump in her breast, it might be cancer.
_Agree
_Not Sure/No Opinion
_Disagree
_No Response
g. It is important that every woman have a mammogram regularly.
_Agree
_Not Sure/No Opinion
_Disagree
_No Response
h. If cervical cancer if found and treated early, it can be cured.
_Agree
_Not Sure/No Opinion
_Disagree
_No Response

i.

It is important for a woman to see a health care practitioner for any unusual discharge or
bleeding from the vagina.
_Agree
_Not Sure/No Opinion
_Disagree
_No Response
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j. It is important that every woman have a pap test regularly.
_Agree
.
_Not Sure/No Opinion
_Disagree
_No Response
BREAST PHYSICAL EXAM
11. Now I'm going to ask you some questions about breast physical exams by a doctor, nurse, or
other health care practitioner. Have you heard about breast physical exams?
_ _Y,es
No
--O:on't Know
_ _,No Answer
12. Would you describe a breast physical exam? {Check if description is:}
Complete
Partial
--:Oon't Know
_ _,No Answer

13. Have you ever had a breast physical exam?
Yes
-No
-Don't Know
No Answer

14. How many times in the last 24 months (2 years) have you had a breast physical exam?
Number
--Don't Know
_ _No Answer

15. As near as you can remember, what was the month and year of your most recent breast
physical exam?
_----,Month
- -Year

16. Where did you have it done?_ _----:-

_

17. Was any problem found?
_ _Y,es
No
--'Don't Know
_ _No Answer

18. Do you plan to have a breast physical exam in the next 2 years?
_ _Yes
No
--Don't Know
_ _N, 0 Answer

19. Do you know anybody else who has had a breast physical exam?
_ _Y,es
_ _,No
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20. Who was it?---,,.-,.,-_o:--:--:--",:,,:,
(What is her relationship to the respondent?)

21. What was her experience with the exam?
Positive
--:Neutral
_ _N,egative
22. In the last 12 months where have you read or heard about breaSt physical exams?
_ _I have not read about or heard about breast physical exams.
IHS Clinic
--:Television
_ _,Radio
____Local Newspaper
_
name
____School
_
_ _Other (specify)
_ _No Answer
23. Would you preferto have a male or female health care practitioner perform the breast physical
exam?
No Preference
-Prefer Male
-Prefer Female
-Don't Know
No Answer
24. Would you personally refuse a breast physical examination if only male health practitioners
were available to do it?
Yes
-No
-Don't Know
No Answer

25. Do you think your husband or partner would object to your getting a breast exam by a male
doctor?
Yes
-No
-Don't Know
=NoAnswer

.

26. About how often do you think a healthy woman your age should have a breast exam by a health
practitioner?
_ _~At least once a year
_ _Every 1-2 years
_ _Once every 2-3 years
_ _0, nee every 4-5 years
Less than once every 5 yrs.
--Only when (or whenever) there's a problem
_ _Only when she is pregnant
_ _O,nly when a doctor/nurse recommends it
___Don't Know
No Answer
--Other (specify)
_
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MAMMOGRAPHY
27. Now I'm going to ask you some questions about mammograms. Have you heard about
mammograms?
Yes
-Not Sure/Don't Know
-No
No Answer

28. Would you describe a mammogram? (Is description:)
_Complete
Partial
-Don't Know
No Answer

29. Was it a screening?
Yes
-No
-Don't Know
No Answer
30. How many times in the last 24 months (2 years) have you had a mammogram?
Number
-Don't Know
No Answer

31. As near as you can rememberwhatwasthe month andyearofyour most recent mammogram?
Month
Year

32. Where did you have it done?
33. Was any problem found?
Yes
-No
-Don't Know
No Answer
34. Do you plan to have a mammogram in the next 2 years?
Yes
-No
-Don't Know
No Answer

35. Do you know anybody else who has had a mammogram?
Yes
No

.

36. Who was it?,~_.,......,..........,....-__
(What is their relationship to person)
37. What was their experience?
_ _P,ositive
_----:Neutral
_ _Negative
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38. In the last 12 months where have you read about or heard about mammograms?
_ , have not read about or heard about mammograms.
IHS Clinic
-Television
-Radio
Local Newspaper
_
name
School
.
Other (specify)
_
_ No Answer
39. Would you prefer to have a male or female health care practitioner perform the mammogram
or do you have no preference?
No Preference
-Prefer Male
-Prefer Female
-Don't Know
No Answer
40. Would you personally refuse a mammogram if only male health practitioners were available
to do it~
Yes
-No
-Don't Know
No Answer

41. Do you think your husband or partner would object to your getting a mammogram by a male
practitioner?
_ _Yes
No
--Don't Know
_ _No Answer
42. About how often do you think a healthy woman your age should have a mammogram done?
_Every year
_Every 1-2 years
_Every 3 years
_Every 4 years
_More than 5 years

43. Now, I'm going to ask some questions about Pap smears or Pap tests. Have you heard about
a Pap smear or Pap test?
Yes
-No
-Don't Know
-No Answer
44. Would you describe how Pap tests are done?
_·Complete
Partial
-Don't Know
No Answer
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45. Have you ever had a pelvic examination?
Yes
-No
-Don't Know
No Answer

46. Have you ever had a Pap test?
.
Yes
-No
-Don't Know
No Answer

47. As near as you can remember what was the month and year of your most recent Pap test?
_----;Month
_ _Year

48. Was any problem found on the exam?
Yes
-No
-Don't Know
No Answer

49. Where did you have it done?

_

50. Do you plan to have a Pap test in the next 2 years?
Yes
-No
-Don't Know
No Answer

51. Do you know anybody else who has had a Pap test?
Yes
No
52. Who was it?_....,....-,...-.....,.....,._
(what is their relationship to the person)

name
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55. Would you prefer to have a male or female health care practitioner for a pelvic examination?
NOPffi~ffin~ .
.
-Prefer Male
-Prefer Female
-Don't Know
No Answer
56. Would you personally refuse a Pap test if only male health practitioners were available to do
it?
Yes
-No
-Don't Know
No Answer

57. Do you think your husband or partner would object to you getting a pelvic examination by a
male practitioner?
Yes
-No
-Don't Know
-No Answer
Not Applicable

58. Aboutllow often do you think a healthy woman your age should have a Pap test done?
BREAST SELF-EXAMINATION

59. Now I'm going to ask you some questions about breast self-examination. Have you heard
about breast self-exams?
Yes
-No
-Don't Know
No Answer

60. Would you describe a breast self-examination?
_Complete
Partial
-Oon'tKnow
No Answer

61. Do you examine your breasts?
Yes
-No
-Don't Know
No Answer
62. How many times in the last 12 months have you examined your breasts?
More than once a month
-Once a month
Not every month but several times a year
_At least once a year
_Less than once a year
_Never

66

63. When was the last time you examined your breasts?
_Less than 6 months ago
_6 months to 1 year ago
_1-2 years ago
_3-5 years ago
_More than 5 years ago
_Don't Know
64. Have you ever noticed anything wrong in your breast? Su.chas pain, a lump, or maybe
something like a discharge?
_ _Y,es
_ _,No
64a If yes, did you go to a health care practitioner about it?
_If Yes, what happened?

_If No, why not?

65. Do you plan to self-examine you breasts in the future?
Yes
-No
-Don't Know
No Answer
66. Do you know anyone who self-examines her breasts?
Yes
No
--;--:--:=-:-_
67. Who is this?
(How is this person related?)

68. What is their experience with breast self-examination?
Positive
-Neutral
Negative
69. In the last 12 months, where have you heard about or read about breast self-examination?
Have not read or heard about SSE.
-IHS Clinic
.
-Television
-Radio
Local Newspaper
_
name
School
Other (specify)
_
_ No Answer
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70. About how often do you think a healthy woman your age should self-examine her breasts?
_Once every month if over 20 years of age
_At least once a year
_Once every 2-3 years
_Once every 4-5 years
_Less than once every 5 years
_Only when there is a problem
_Only when she is pregnant
_Only when recommended by doctor or nurse
Don't know
-No Answer
Other (specify},
_

GENERAL INFORMATION
Now, we are on the last section of the questionnaire. Since there may be a relationship between
a woman's opinions about cancer and the number of children and pregnancies she has had, I need
to ask just a few questions about these issues. Of course, all this will be kept strictly confidential.
You do not have to answer any of these questions if you do not feel comfortable answering them.
71. First, what is the year of your birth?

-"----__

72. Do you have any children?
Yes
-No
No Response
If Yes,
72a.,

How many?

72b.,

How old were you when your last child was born?

72c.,

How many times have you been pregnant?

72d.

Howald were you the first time you became pregnant?

73. Are you working outside your home at this time?
_ _Yes
_ _No
73a. If Yes,
_ _Full time
_ _Part time? If part time, _ _how many hours per week?
74. Are you responsible for the care of any pre-school age children?
Yes
No
74a. If Yes,
Number

--
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74b.

How often daily:

_3-4 days/week
_1-2 days/week
75. What was the highest grade in school that you completed?

_

76. Do you have health care insurance?
Yes
No
If Yes,
76a. Does it cover mammograms and Pap tests:
Yes
-No
-Don't Know
No Answer
76b. What type of health insurance?
Medicare
--:Medicaid
_ _Other (specify)_ _
77. Describe all your tribal affiliations:

78. That's the end of our questionnaire. That took about,
help.

minutes (hrs). Thank you for your

79. Were there any questions that were not clear to you?
Yes
--No
If Yes,
79a. Which ones?
Question #

Reasons

INTERVIEWER (FEEDBACK) INFORMATION

1. Place of interview:
-Home (specify)
_ _Other

2. Was there anyone else there that helped interpret or explain questions?
_ _Yes
_

_N ,

0
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IfVes,
2a. Who (specify, relationship, no names)
2b. Did they help respondent with the answers?
Ves
No
2c. Why did respondent need help?
3. In addition to questions in 79a, were there any others that appeared to be difficult for this
respondents to understand?
Lis~

question # and reason:

4. Was the respondent impatient with the interview or in a hurry to get it over?
':'Yes
-Not Sure
-No

5. How embarrassed or uncomfortable was the respondent during the interview?
_Very
_Slightly
_Not At All

6. Do you think that the woman accepted the questions as important ones to answer?
Ves
-Not Sure
-No
7. Anything else noteworthy about this interview?
Ves
No
If Ves, check all that apply:
_ _Wanted to chat
_ _Offered (non-health) information about self
_ _Offered information about health
_ _Offered information about cancer (specify)

8. Do you personally know this respondent?
Ves
No
If Ves, is she a
Relative
-Friend
Neighbor
_Other (specify)

_

9. Check incorrect information given by the respondent about the follOWing?
_Breast physical exam
_Mammography
_Pap
_Breast self-exam
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VI. KNOWLEDGE, ATTITUDES, AND PERCEPTIONS OF IHS PROVIDERS
REGARDING CANCER PREVENTION AND CONTROL
A. Introduction
As part of the general concern regarding the relatively poor survival rates for American Indian

and Alaska Native (AIl AN) women diagnosed with breast or cervical cancer, the Indian Health .
Service (IHS) Office of Health Program Research & Development (OHPRD) in Tucson, with
funding support from the lliS Office of Planning, Evaluation & Legislation (OPEL) and from the
National Cancer Institute (NeD engaged. in a coordinated. set of research projects. These several •
projects are designed to accomplish multiple broad goals:
...to review and refine information on morbidity and mortality rates for breast and cervical
.
cancer among AIl AN women in selected. locations, using multiple data sources,
...to retrospectively review the clinical system's diagnosis and treatment of actual cases in an
effort to clarify practices and identify possible missed opportunities for early detection, and
...to identify those beliefs or attitudes of providers and patients which might alter the
opportunities for early detection of breast andlor cervical cancer.
The following is a description of that component project dealing only with the knowledge,
attitudes and practices (KAP) of IHS providers.
B. Methodology

Early in the development of this project, the principal investigator assembled severalOHPRD
staff members involved in the various component studies of this cancer research in order to discuss
and clarify fundamental approaches to the project. It was through this process that an understand
ing was reached on the basic format for the survey.
It was agreed that concurrent research activities on the various component studies would

benefit most from an initial ''broad brush" survey of attitudes which could later become more
focused on identified issues in subsequent follow-up iterations of the survey. This anticipates the
possibility, or probability, of a phasic approach to the project,...that an initial survey may likely
identify' questions which we will want to pursue in more detail through additional study.
Given the "broad brush" aspect of the initial survey, it was decided to opt for the use of a fairly
brief questionnaire for the data collection instrument, as opposed to the use of telephone
interviews or in-person inquiries with a number of providers. This option probably provides us
with input from the greatest number of respondents and can be done quite economically,... though
it does sacrifice some detail and clarity of response by obviating the opportunity to immediately
pursue any response in a conversational mode or to "read" the emotional tone of the responder.
There are offsetting advantages and disadvantages involved in almost every aspect of the survey
design. An additional advantage of the questionnaire is that it allows us to assure the respondent's
anonymity, thus gaining a theoretical degree of candor in their responses.
However, granting anonymity to the respondent also eliminates the possibility of doing any
detailed comparison between that respondent's stated beliefs and practices, and their actual
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clinical performance. The possibility of utilizing a methodology for matching individual perfor
mance with knowledge and beliefs is not ruled out for subsequent phases of the study, but was
not built into the first phase.
Decisions regarding the scope of the provider survey relate to both the types of providers who
would be surveyed and the geographic area to be covered. Since the research question concerns
everything from teaching breast self-examination and chemotherapy to setting up patients for
pe1vicexams and pap smears,...activities which involveeciucation, community outreach, outpatient
and inpatient operations, we felt it important that the initial "broad brush" survey be inclusive of
a full range of provider types. Thus, distribution of questionnaires would go to physicians, non
physician primary care providers (NPPCPs), RNs in both the inpatient and outpatient clinical
setting, and community health providers in a non-clinic mode. likewise, in being inclusive, we
. elected to restrict the geographic area for the survey in order to be dealing with a manageable
number of respondents. It was originally intended to distribute the initial questionnaire to 3lliS
Areas - Phoenix, Navajo and Aberdeen. However, serious delays ctJ\d difficulties were encoun
tered in getting a reliable listing of current provider personnel from the Aberdeen Area, so the final
mailing was limited to 743 providers in the Phoenix and Navajo Areas. This compromises our
opportunity to compare provider perceptions in the northern tier with those working on the
southwestern reservations
Since this study is being performed under the general rubric of a provider KAP survey, it is
important to understand that the initial "broad brush" phase was not planned or conducted with
a full spectrum of attention devoted to knowledge, attitudes and practices. As has been
mentioned, the anonymity of the respondents does not permit the matching of clinical practices
to stated attitudes, so the initial questionnaire was intentionally design d with minimal inquiry
about the actual practices of the respondent. Also, the decision w s made to provide the
respondent with a set of generally accepted screening standards for com ent, rather than to "test"
the respondent's knowledge of screening criteria or the pathophysiolo y of breast and cervical
cancer. Thus, the first questionnaire is essentially an attitudinal survey hich attempts to achieve
the following objectives:
!

...to assess provider attitudes toward prevention, generally, and howj they see their role in the
screening function, in particular
.
!

...to assess provider perceptions of an ideal or improved approach ~o cancer screening and
some of the more obvious obstacles to achieving those improvem~nts
...toidentify any differential between attitudes toward the early dete<1ion of breast cancer, and
the early detection of cervical cancer
.

i
...to utilize a format which enables us to identify group variations in ~rception based on age,
amount or type of training, gender or clinical experience of the respondents.
C. Development of the Questionnaire

A literature search was performed, seeking any study which had raised similar questions
regarding provider KAP for the prevention of illness, barriers to implementation of prevention
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practices and, in particular, any which dealt with attitudes toward screening for breast or cervical
cancer. Quite a few articles were identified (see bibliography) and summaries or reprints of most
of them were obtained. Generally, they were helpful in suggesting concepts which we might use,
but lacking in the sort of specificity that might have rendered them useful in making comparisons
between populations or in providing an easy format for use in our own questionnaire.
The provider group queried in virtually all of the studies we identified consisted of physicians
only. The subject of the study questions in those articles ranged from nutrition counseling and
smoking cessation to periodic health examinations. However, the majority of reports dealt with
physician attitudes and activities as they related to health promotion and disease prevention in the
primary care setting. Several of the studies dealt, at least partially, with screening for breast and/
or cervical cancer. These were predominantlyof three types, with varyingbenefits and drawbacks:
(a) Telephone interviews of approximately 25 minutes duration, comparing attitude~ and
--:beliefs with self-reported practices. This method proviges better penetration of the
-.: selected population (one study reported only 14 refusals of 134 physicians called), but at
:'~ a somewhat higher cost than a mailed solicitation,...and the subjective responses are more
"'likely to display a normative bias, especially regarding the self-reported practices.
(b) Chart reviews and direct interviews for the purpose of comparing stated attitudes and

actual clinical practices. An excellent technique which provides hard objective data, but
is limited in terms of both the limited scope of questions it answers, and the much higher
cost per respondent.
(c) Mailed questionnaires provide a relatively low cost data collection mechanism, but are
troubled by lower response rates among the selected population (one study in New York
State had a fairly impressive 53% return),...and are subject to greater variation in how
questions are read and interpreted by the respondents. Response rates can be increased
by employing elaborate follow-up "reminder" systems without sacrificing the anonymity
of the respondent, but this makes the process significantly more complex and increases the
time required for completion of the survey.
Table 1:
Examples of published studies
Method Used

N

Practices in primary
care prevention...........

phone interviews

120

Ca detection attitudes
and practices.............

phone interviews

1035

Prevention/scmg. stds.
vs. physician practices..

Record reviews &
patient interviews

Performance on 7
Ca screening tests........

Record reviews &
MD interviews

Mammography scmg....

Mailed question're

Subject of Study

Population

Date

Primary care
physicians (NYC)

1984

Primary care
physicians (US)

1984

83

Physicians (Mass)

1982

52

Internists (Calif)

1981-82

Family phys.(NY)

1982

370
(of 509)
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We decided to proceed with the simplest and least expensive option for the "broad brush" initial
phase of our study:
During October, 1989, an alpha test ofthe questionnaire was done attheSells Service Unit, with
distribution of 29 questionnaires to physicians, clinical nurses and public health nursing staff.
Comments were invited on the structure, understandability and pertinence of the questions, as
well as having respondents complete the questionnaire. Thirteen responses were received for a
45% return. No respondent offered suggestions for change in the format or reported experiencing
any difficulty in completing it.
Thus, in November, general distribution was made by mail to the two target ll-IS Areas with
a franked return envelope addressed to the principal investigator. Return envelopes were coded
to identify the geographic ll-IS Area of the respondent while preserving their anonYmity.
Recipients of the questionnaire were selected by their job title and functional location in the h,ealth
care delivery-system, with the intent of reaching those most directly associated with the screening
and treatment of women subject to cervical and breast cancer. The group consisted of medical
officers and nursing staff (except LPNs and Nurse Aids) assigned to general outpatient clinics and
medical/surgical inpatient wards, nurse midwives, nurse practitioners, physician's assistants,
community health nurses, and just a handful of "special interest" folks such as general surgeons,
nursing health educators or discharge planners were included.
Table 2
Questionnaire Distribution
Location

Physician

Mid-level
pract'ners

PIMC
Keams Canyon
Owyhee
Sacaton _
San Carlos
Schurz
WhiteRiver
Cibeque
Yuma
Phoenix Area:

28
8
4
7
3
7
11
2
4

1
1
1
2
3
3
0
0
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16

Chinle/Tsaile
Crownpoint
Ft. Defiance
Gallup /Tohatchi
Kayenta/Inscr. House
Shiprock/Huerfano
Tuba City
Winslow
Navajo Area:

23
12
13

Clinical
Nursing

PHNs
& Others

Totals

5
12
5
11
12
4
33
2
9
123

35
5
2
3
5
4
8
1
1

7

36

249

35

11
24
20
9

9
3
6
11
3
9
10
3

134

54

240

8
6
7
9
0
13
8
4
55

483

22

22

36
46

9
44

38
10
75

Of the original mailing of 743 questionnaires, 11 were returned by the postal system .
"undelivered" due to transfer of the addressee to a new assignment and, therefore, are not
included in the distribution displayed above. Ultimately, 307of the 732 delivered questionnaires
were completed and returned to theprincipal investigator. A somewhat typical, butdisappointing,
response rate of 41.94% overall. Those most likely to respond were apparently the community
health categories (PHNs, health educators, discharge planners, etc.) who returned 69.2% those
delivered. Nurses in active clinical roles, outpatient or inpatient, were the least likely to respond
(and likely the busiest of the recipients), with 30.0% being returned. 42.3% of the physicians
responded, and 44.3% of the so-called "mid-level" practitioners.

Since there was some concern over assuming that the 40+% who voluntarily responded
actually represented the attitudes of the target provider group, a summary of the hard data and
a questionnaire were sent to an accepted expert, Dr. Lee Sechrest at the psychology Department
of the University of Arizona, for his evaluation. He commented that, even though the retur!). was
small, the absolute number was large enough and the questionnaire sufficiently straight-forward
to draw conclusions which should be reasonable. He believes that "internal coherence" was
present in the process and pointed out that, in other similar surveys, it has been hard to find
substantial differences between responders and non-responders.
There was little difference in the response rate between IRS Areas, with 110 of 249 (44.58%)
returned from the Phoenix Area providers and 196 of 483 (40.58%) from those in the Navajo Area.
A template was prepared in dBase ill for input of the responses and a clerk assigned to enter
the data. The data from the 307 coded questionnaires was analyzed through multiple computer
runs as well as by careful review of the narrative comments which accompanied the objective
responses.
D. Results
Response rates by categories: (% returned of those mailed out)
Phoenix Area:
Phy~icians ..

Mid:levels .
Clin: Nurses..
Community...

35.1%
50.0%
31.7%
86.1%

Navajo Area:
Physicians .
Mid-levels .
Gin. Nurses .
Community .

46.3%
42.6%
28.3%
61.8%

There was a considerable store of experience behind the data collected in this survey. Of the
physicians responding, 76% were board certified in their specialty. Among the entire group of
respondents, two-thirds were over 35 years of age and had greater than 5 years of clinical
experience in their professional field. The median age of respondents was 39-40 years and they
had a median of 9-10 years clinical experience.
Among both the NavajO and Phoenix Area respondents, 70% of the physicians were males,
while the other professional subgroups were dominantly (79% to 89%) females. Only 70.6% of the
Navajo physicians are board certified, as compared to 90% of the Phoenix Area doctors. The
physician group tends to be the youngest (53% are 35 or under). The majority (69% to 73%) of the
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other professional groups are over 35 years ofage. As a group, the physicians also have less clinical
eXPerience (64% under 5 years) than the other professional groups (77% to 81 % over 5 years).
Results: The following represents a summary of that analysis, taken question by question.
Question #1 - What do you believe are the most significant reasons for poor health status in the population

served by your service unit?
Most
Signif.
Inadequate access to curative
health services
Inadequate patient understanding
of prevention
Lack of jobs or economic
opportunity
Alcohol and/or substance abuse
Inadequate budget for health
programs
Insufficient skilled health care
providers
Poor nutrition
Lack of educational opportunity
Poor housing
Environmental health problems
Inadequate sanitation
.Community apathy
Bureaucratic incompetence

Moderate Average
Signif.
Signif.

Little
Signif.

No
Signif.

18

58

68

72

30

120

91

36

7

1

59
130

88

29
17

11

71

64
35

85

87

52

22

10

33
47
43
43
37
38
73
64

49

54

84

78
90
82
83
70
66
69

76
37
41
49

2
6
14
14
9
14
5
17

65
64

78
80
85
66

44

51
19
36

2

Those categories which prompted 70 or more positive responses are boldface to illustrate the
dominant view that the principal causes of poor health status are alcohol or substance abuse,
inadequate understanding of prevention, limited budget resources and community apathy. Also
of interest is the perception among the provider group that access to health care and sufficient
skilled providers are not major problems (keep in mind that this data is from the Phoenix and
Navajo Areas), and recognition that soCia-environmental factors such as jobs, nutrition, housing
and sanitation are significant contributors to community health status.
. In fact, there was a significant difference in emphasis in the rating of causes for poor health
status between the Phoenix and Navajo Areas. Phoenix rated "alcohol and/ or substance abuse"
and "community apathy" somewhat higher than did Navajo providers. And Navajo providers
understandably rated the importance of '1ack of education", "poor housing", "sanitation" and
"environmental problems" a bit higher than those in the Phoenix Area.
A careful analysis ofall responses by demographic provider subgroups of gender, age, clinical
experience and professional classification (physicians, mid-level practitioners, nurses and others)
revealed some interesting insights:
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• There was a general tendency for female respondents to rate all issues as more significant
than their male counterparts.
• Respondents over age 35 were more likely to rate issues in the extremes (high or low),
displaying a more "opinionated" position than those 35 or younger who tended to group
more toward the middle rating values.
• In general, the more highly trained the provider, the lower their ranking of "poor nutrition"
as a significant cause of poor health.
Question #2 - What is your perception of the prevailing attitude toward preventive medicine among the

providers at your service unit?
On a scale of o-"little interest" to 10-"enthusiastic", the mean response was 6.21.
The most frequently selected value was 8 (second most frequent value 5).
Those ~lecting high values:
(6 to 10 on a scale of 0-10)

Physicians
Mid-levels
Nurses
Others

.
.
.
.

82.0%
57.7%
66.3%
32.8%

This was the first of four questions (Q.. #2, 3, 8 and 13), to which the response displayed a
curious phenomenon. On all these offering a 0 to 10 scale, "peaks" of response tended to uniquely
occur at the 3,5, or 8 values. It would appear that respondents inadvertently chose to simplify the
scale by opting for a "below average" (3), "average" (5), or "above average" (8) response.
As a rille, the younger providers were more positive in their rating of local attitudes toward
prevention (only 27.8% scored 5 or less on a 0-10 scale), while those over age 35 expressed some
comparative cynicism (43.2% scored 5 or less). yet, in responding to question #3 (below), the
younger providers thought less effort was being devoted to early detection than did their
counterparts over the age of 35. NavajO providers rated themselves higher on prevention than
Phoenix providers.

Question #3 - In your opinion, how much attention and effort is currently being directed to early detection
ofcancer by the providers at your service unit? (Separate responses were requested for breast cancer
and cervical cancer.)
On a scale of 0 to 10, the mean response for breast cancer was 4.63.
the most frequently selected value was 5 (second most frequent value 3).
On a scale of 0 to 10, the mean response for cervical cancer was 5.79.
the most frequently selected value was 5 (second most frequent value 8).
Note: A minority of responses assigned the same value toboth categories, but most responders
rated the attention given to detecting breast cancer 2 to 4 integers below that for cervical cancer.
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Question #4 - Do you think IHS should establish "dedicated" clinic sessions with specially trained female

staff(NPs) as women's health providers for the sole purpose ofdealing with reproductive health issues, such
as family planning, breast/cervical cancer screening, STD screening, prenatal care, breast-feeding and
counseling on parenting matters?
Yes - 210 (81.4%)No ~ 27

Undecided - 21

This was one of the most consistently positive responses to the questionnaire, yet marked by
some polarization. Most of the positive reactions were accompanied by a narrative statement
about female patients being more comfortable with female providers, and urging the provision of
a setting to accommodate this sensitivity. Some of those opposed. to this approach expressed
concerns over further "fragmentation" of the delivery system.
There is a slight negative bias revealed among the under age 35 providers (physicians?)., and
some apparent gender bias. While only 14.1 % of females answered "no" or "undecided", that
count among the male respondents was 27.8%. By professional groups, the "yes" responses were:
physicians...............
midlevels................
nurses
:......
others......................

71 %
88%
79%
95%

Question #5 - Where do you think screening for breast and cervical cancer is most effectively accom

plished?
Emergency Room - 8
Inpatient Admissions - 40

General Outpatient Clinic - 105
Women's Clinic -188
Prenatal/Gynecology Clinic - 171

This requires little comment. There was little or no difference of response to this question
based on gender, geographic location, age, experience of professional subgroup.
Question #6 - Should IHS adopt a set of screening and follow-up standards for use by all IHS provid

ers? Or is it better to rely on the clinical judgement of each provider in their own setting?
Develop illS standards that all IHS providers will be required to use -119
Develop illS standards only as a guide for individual judgement - 126
Allow individual providers to apply their own standards and preventive methods - 9
Almost no one pointed out that we already have existing IRS standards in place, but the
response reflected an impressively even split between the hard-line rule followers and those
providers who need a bit more "elbow room" in their practice. Generally, over age 35 providers,
females and the Phoenix Area providers tended to favor required use of the lliS screening
standards, while younger providers, males, and thoseon theNavajo Reservation preferestablishing
standards only as a guide for clinical practice. There was a readily evident attitudinal split
between the professional SUbgroups:
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Physicians strongly prefer guidelines only (78%)
Mid-levels and Others prefer required standards (61-72%), and
Nurses split evenly between the two.
Question #7 - Belaw are some generally accepted screening recommendations for early detection ofcervical

and breast cancer in asymptomatic women. Please indicate with acheck mark which you actuallYfollaw in
your practice, and which might be unrealistic in your present setting.
Age
Pelvic exam
Pap smear

20-65
20-65

Breast self-exam
Breast MD exam

>20
20-40
>40
35-40
40-50
>50

Mammography

Frequency

Actual Practice

Unrealistic

139 (67.8%)
155 (80.7%)

66
37

131 (66.5%)
149 (79.3%)

66
39

43 (23.0%)

144

annually
Q 3 yrs. after 2
init. neg. exams
monthly
Q3yrs.
annually
baseline
Q 1-2 yrs.
annually

A significant majority of responders were comfortable with the standards for pap smears and
breast exams by the provider, and were troubled mostly by the time pressures in their clinic setting
which make it difficult to carry them out. There was slightly less accord on the necessity of an
annual pelvic exam and the efficacy of devoting busy clinic time to teaching BSE techniques.
The narrative comments accompanying the negative responses on the mammography stan
dards made it clear that this was not a rejection of the screening standards, but an expression of
the fact that this practice is "unrealistic" from the standpoint that they do not have the resources
to get mammography done.
Question #8 - Knawing that many women are reticent about submitting to pelvic or breast exams, based

on personal discomfort or embarrassment, what is your honest assessment ofthe chancesfor improvingearly
detection of breast and. cervical cancer among Indian women?
On a scale of 0 to 10, the mean response was 6.02.

The I?ost frequently selected value was 8 (second most frequent value 5).
The older provider group assessed the chances of improving early detection with less
optimism (53% chose 5 or less on a 0-10 scale, while only 28.6% of the younger group rated it that
low). Also, females tended to rate either low or high on this question, while males gave more
"normative" middle-ground responses. The full break-down of responses was as follows:
1 - 2.0%
6 - 8.3%
2 - 5.5%
7 - 13.8%
3 - 10.7%
8 - 19.0%
4 - 9.9%
9 - 4.3%
5 - 17.0%
10 - 9.5%
There was considerable "spread" in responses, and the disparity of attitude was true of all
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There was considerable "spread" in responses, and the disparity of attitude was true of all
professional subgroups. The answer to this question is so important, and the above data so
amorphous, that this subjectobviously needs further investigationin an attemptto resolve the true
potential for change through intervention.
Question #9 - Of the following, which do you believe are reasons that providers at your service unit may
not routinely perform screening tests on their asymptomatic patients?
Always
30
110
20
13
1

Inadequate clinical space................................
Lack of time in busy schedule.......................
Forgetfulness or inadequate reminders......
Doubtful benefit of tests, considering cost..
Risk of complications......................................
Lack of provider interest-in prevention......
Questionable validity, sensitivity
or value of screening test..............................

Often Sometimes
70
90
69
41

78
46

Seldom
72
7

108

54

56

22

11
30

39
87

138
197
111

5

18

76

149

On the whole, the older (over age 35) providers tended to rate all reasons for not performing
screening tests more highly than the younger group. We can only speculate as to whether this
might be an attempt at justification for doing less screening (see Q.13) or possibly a reflection of
the stronger biases which were demonstrated in their responses to question #1. We also note that
female providers tended to rate all reasons more highly than male providers.

The physician group emphasized the "inadequate clinic space", as well as the "lack of time in
a busy schedule" which got high scores among all examined subgroupings. In comparing geo
graphic areas, the ''lack of time" and "inadequate space" issues were more ofa perceived problem
for the Navajo providers than for those in the Phoenix Area.
Question #10 - At present, mammography is not widely utilized by IHS or private practitioners. Do you
believe mammography would be generally accepted and utilized by the Indian women, if it were more
accessible and available?
Yes -186 (72.l-%)No - 20

Undecided - 52

Considerable indecision persists among our providers as to whether or not Indian women
would readily utilize mammography as a screening methodology. The younger providers and the
physician group were slightly more optimistic about the acceptance of mammography by Indian
women, but there was relatively little difference in attitude between the various subgroups. Most
notable is the degree of uncertainty among the women and non-physician respondents.
Question #11 - Considering the high cost, do you think mammography would be an appropriate use ofour
limited lJudget funds?
Yes -138 (55.0%)No - 49

Undecided - 64
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There is even greater skepticism among our providers about diverting tight resources into an
expensive mammography screening program. Analysis of responses to this question revealed
remarkably little difference in attitude between any of the subgroups....by age, gender, experience,
location or professional training.
Question #12 - Would you more frequently order mammography for your patients if it were more readily

available?
Yes -183 (81.3%)No - 18

Undecided - 24

Responses from the female providers were heavier on the "undecided" or "no" response, and
many of the female respondents commented that they were in support roles and not in a position
to be ordering patient mammograms. Younger providers were somewhat more enthusiastic
(87.5%) about ordering mammography, iffunds were made available, than their olderco-workers
(77.7~J. In any event, based on the highly positive response, we would be assured of high usage
if funding were available for this purpose.
Question #13 - On what percentage ofyouroutpatient visits do you estimate you currently check to seewhat

screening tests are needed,...then recommend or perform those tests?
The most frequently selected value was 8 (81-90%)
The second most frequent value was 3 (31-40%).
0-10%
19

11-20% 21-30% 31-40% 41-50% 51-60% 61-70% 71-80% 81-90% 91-100%
13
16
26
16
19
12
24
35
20

Isn't this interesting? illS providers assess their own screening activity as being somewhat less
than consistent or ideal. There is no significant difference in this erratic distribution of responses
based on age or geographic area. Physicians, mid-level practitioners and younger providers, in
general, tend to rate themselves as more frequent screeners than their counterparts. Only 31.8%
of those age 35 or under estimated that they check less than half of their patients for needed
screening, while 52.5% of those over age 35 did so.
,

..

Question #14 - Is the Patient Care Component (PCC) ofthe automated RPMS in useat your service unit?
Yes - 61 (25.1 %)

No - 122 (50.2%)

Don't know - 60 (24.7%)

Note: This question was intended only to channel the responder to either 14a or 14b, for inqUiry
into their means of alerting providers to needed screening. Many of those who "didn't know" if
the PCC was in use at their service unit were field workers who have less interaction with the
system. Also, many indicated a lack of familiarity with PCC since it was just being put into use.
Question #14a - If Yes (61 responders), do you use the "health summary" as a reminder to:
update immunizations - 40
do pelvic exams/pap smears - 33
do provider breast exams - 29

teach breast self-examination - 24
order needed lab work - 30
provide patient education - 30
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